1. Introduction {#sec1-ijms-21-02741}
===============

HIV-infected brains tend to have enhanced amyloid beta (Aβ) deposition \[[@B1-ijms-21-02741],[@B2-ijms-21-02741],[@B3-ijms-21-02741],[@B4-ijms-21-02741],[@B5-ijms-21-02741],[@B6-ijms-21-02741]\], mostly in the perivascular space \[[@B3-ijms-21-02741],[@B7-ijms-21-02741],[@B8-ijms-21-02741],[@B9-ijms-21-02741]\]. Indeed, the blood--brain barrier (BBB) is thought to be a key player in the brain's Aβ homeostasis \[[@B10-ijms-21-02741]\]. It is now widely accepted that extracellular vesicles (EVs) may also be important in Aβ pathology \[[@B11-ijms-21-02741],[@B12-ijms-21-02741],[@B13-ijms-21-02741],[@B14-ijms-21-02741],[@B15-ijms-21-02741],[@B16-ijms-21-02741],[@B17-ijms-21-02741]\]. Our earlier work has shown that HIV can increase the release of brain endothelial EVs and alter EV-Aβ levels. Moreover, brain endothelial cell-derived EVs can transfer Aβ to other cells of the neurovascular unit \[[@B18-ijms-21-02741]\]. EVs carry specific cargo molecules, including a complex set of proteins, which can be transferred to the neighboring cells and affect their biology. Some of these proteins are on the EV surface. The surface proteins may allow for selective EV uptake by the recipient cells, like in the case of receptor-mediated endocytosis. Total proteomics can give detailed information on the EV protein cargo overall. Surface proteomics could indicate the "address" of a targeted delivery, while total proteomics would represent the delivered "package."

In this work, we investigated how exposure to HIV, alone and together with Aβ, impacts the surface and total proteomic landscape of EVs from human brain microvascular endothelial cells (HBMEC-EVs). By using this unbiased strategy, we obtained a complex, high-resolution insight into these changes.

2. Results {#sec2-ijms-21-02741}
==========

2.1. Extracellular Vesicles from Human Brain Microvascular Endothelial Cells (HBMEC-EVs) Are Enriched with the Major EV Markers {#sec2dot1-ijms-21-02741}
-------------------------------------------------------------------------------------------------------------------------------

At first, we examined whether proteins that are frequently identified in EVs/exosomes from various sources can be found in our isolated HBMEC-EVs. Based on the ExoCarta EV proteomics database from different human cell types that have been isolated using different approaches \[[@B19-ijms-21-02741],[@B20-ijms-21-02741]\], we compiled the list of 100 marker proteins that are most often present on EVs ([Table 1](#ijms-21-02741-t001){ref-type="table"}). The surface HBMEC-EV proteome, which contained a total of 283 identified proteins, included 62 of the top 100 ExoCarta EV markers ([Figure 1](#ijms-21-02741-f001){ref-type="fig"}A, [Table 1](#ijms-21-02741-t001){ref-type="table"}). In addition, the total HBMEC-EV proteome, which contained 501 identified proteins, included 80 of such markers ([Figure 1](#ijms-21-02741-f001){ref-type="fig"}B, [Table 1](#ijms-21-02741-t001){ref-type="table"}). These results demonstrate that our HBMEC-EV isolation was highly enriched with known EV markers.

2.2. Cellular Component Enrichment of the Identified Surface and Total EV Proteins {#sec2dot2-ijms-21-02741}
----------------------------------------------------------------------------------

Using the Scaffold software, we next evaluated the HBMEC-EV proteins according to their known cellular localization. This approach may indicate the parent cellular compartment origin of the identified HBMEC-EV proteins. The majority of the HBMEC-EV surface proteins were extracellular region proteins, followed by cytoplasmic, intracellular organelle, membrane, nuclear, endoplasmic reticulum, cytoskeleton, Golgi, mitochondrial, endosomal, ribosomal proteins, and one unknown protein ([Figure 1](#ijms-21-02741-f001){ref-type="fig"}C). For the total HBMEC-EV proteome, the majority of proteins were cytoplasmic and extracellular region proteins ([Figure 1](#ijms-21-02741-f001){ref-type="fig"}D).

2.3. HIV and Aβ Exposure Results in Unique HBMEC-EV Proteome Signatures {#sec2dot3-ijms-21-02741}
-----------------------------------------------------------------------

We next focused on the unique proteins induced by the exposure to HIV and Aβ. Comparison of the control vs. HIV surface HBMEC-EV proteomes identified 112 unique proteins in the control and three unique proteins in the HIV group ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}A). By contrast, a similar comparison for the total proteome identified only three unique proteins in the control and as many as 259 unique proteins in the HIV group ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}B). Comparison of the surface proteome between the HIV vs. HIV+Aβ groups identified six unique proteins in the HIV group and 116 unique proteins in the HIV+Aβ group ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}C). Finally, analysis of the total proteome revealed 28 unique proteins in the HIV group and 201 unique proteins in the HIV+Aβ group ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}D). A list of these unique proteins is provided in [Table 2](#ijms-21-02741-t002){ref-type="table"} and [Table 3](#ijms-21-02741-t003){ref-type="table"} for the surface and total proteomes, respectively.

2.4. Functional Enrichment of the Unique HBMEC-EV Proteins {#sec2dot4-ijms-21-02741}
----------------------------------------------------------

We next grouped these unique protein signatures into the biological process categories of the Scaffold software. Overall, 19 main categories were established, and the number of unique proteins mapping to these categories is illustrated in [Figure 2](#ijms-21-02741-f002){ref-type="fig"}, separately for the surface (A and C) and the total proteome (B and D). Note that individual proteins could map to more than one category; on the other hand, not all categories have been identified for all comparisons. This is consistent with the fact that selected group comparisons identified only a limited number of unique proteins that mapped to a limited number of categories. The number of unique proteins corresponding to the main biological process categories in the combined comparisons is illustrated on the bar graphs in [Figure 2](#ijms-21-02741-f002){ref-type="fig"}E for the surface proteome and [Figure 2](#ijms-21-02741-f002){ref-type="fig"}F for the total proteome. The majority of both surface and total unique proteins were mapped to "response to stimulus," "multicellular organismal process," "metabolic process," and "localization" categories.

Next, we evaluated the unique proteins in the control vs. HIV and in the HIV vs. HIV+Aβ comparisons using STRING for functional enrichment in the biological processes and the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways. In addition, we enriched these analyses for cellular components and PMID publications.

The results of these analyses for the EV surface proteome unique proteins in the control group in the control vs. HIV comparison are listed in [Table 4](#ijms-21-02741-t004){ref-type="table"} and [Supplementary Table S1A](#app1-ijms-21-02741){ref-type="app"}. In addition, [Supplementary Table S1B](#app1-ijms-21-02741){ref-type="app"} lists the enrichment for cellular components. The observed gene count (Obs), background gene count (Bgr), false discovery rate (FDR), and matched proteins are also included in these tables. The three unique proteins identified when comparing the surface proteome in the HIV group to the control group are dynein heavy chain 8, axonemal (DNAH8), titin (TTN), and immunoglobulin heavy constant gamma 2 (IGHG2). According to the description in the STRING or GeneCards database, DNAH8 is a force-generating protein of the respiratory cilia and is also involved in sperm motility. In addition, DNAH8 is highly expressed in prostate cancer \[[@B21-ijms-21-02741]\]. Titin appears to be a key component of the vertebrate striated muscles \[[@B22-ijms-21-02741]\]. IGHG2 may take part in antigen binding and the regulation of actin dynamics. It was linked to severe respiratory syncytial virus infection \[[@B23-ijms-21-02741]\]. Overall, very limited or no data were found for the different enrichment analyses in STRING regarding these three proteins.

Next, we analyzed the EV surface proteome unique lists for the HIV vs. HIV+Aβ comparison in order to dissect the effect of exogenous EV-Aβ cargo in the context of HIV. In this analysis, six unique proteins were identified in the HIV group, namely, TTN, ninein (NIN), DNAH8, adenylyl cyclase-associated protein 1 (CAP1), actin-related protein 2/3 complex subunit 4 (ARPC4), and IGHG2. For these unique proteins, all enriched biological processes are shown in [Table 5](#ijms-21-02741-t005){ref-type="table"}. No KEGG pathways were enriched; however, several PMID publications were found by textmining ([Table 5](#ijms-21-02741-t005){ref-type="table"}). Cellular localization of these enriched proteins to only a few categories was found, namely, "cytoskeletal part" (ARPC4, CAP1, DNAH8, NIN, TTN), "actin cytoskeleton" (ARPC4, CAP1, TTN), "supramolecular fiber" (DNAH8, NIN, TTN), "microtubule" (DNAH8, NIN), "ciliary part" (DNAH8, NIN), and "cytoplasmic region" (CAP1, DNAH8).

For the unique proteins in the HIV+Aβ group in this comparison, the enriched biological processes, KEGG pathways, and PMID publications are presented in [Table 6](#ijms-21-02741-t006){ref-type="table"} and [Supplementary Table S2A](#app1-ijms-21-02741){ref-type="app"}. The enrichment for cellular components is included in [Supplementary Table S2B](#app1-ijms-21-02741){ref-type="app"}.

Next, we analyzed the EV total proteome unique lists for the control vs. HIV comparison. For the unique proteins in the control group, no gene ontology (GO) terms were found for biological processes. Similarly, no KEGG Pathways were enriched, likely because only three unique proteins were identified in this group and comparison. The cellular localization of these proteins is presented in [Supplementary Table S3](#app1-ijms-21-02741){ref-type="app"}. In addition, the first 10 PMID publications enriched are shown in [Table 7](#ijms-21-02741-t007){ref-type="table"}. The total proteome revealed 259 unique proteins in the HIV group that mapped to a variety of GO terms for biological processes ([Table 8](#ijms-21-02741-t008){ref-type="table"} and [Supplementary Table S4A](#app1-ijms-21-02741){ref-type="app"}). They were also enriched in several KEGG pathways ([Table 8](#ijms-21-02741-t008){ref-type="table"}) and assigned to diverse cellular components, as listed in [Supplementary Table S4B](#app1-ijms-21-02741){ref-type="app"}. Textmining resulted in an unbiased PubMed search with the 10 most significant publications listed in [Table 8](#ijms-21-02741-t008){ref-type="table"}.

Finally, we analyzed the list of the unique proteins present in the total HBMEC-EV proteome in the HIV and HIV+Aβ groups. The unique proteins in the HIV group in this comparison mapped to only one GO term for biological processes, namely, "cell envelope organization," presented in [Table 9](#ijms-21-02741-t009){ref-type="table"}. No KEGG pathways and no cellular components were enriched for this group. The first 10 textmined PMID citations are presented in [Table 9](#ijms-21-02741-t009){ref-type="table"}. The unique proteins in the HIV+Aβ group were enriched to several biological processes, KEGG pathways, and PMID publications ([Table 10](#ijms-21-02741-t010){ref-type="table"} and [Supplementary Table S5A](#app1-ijms-21-02741){ref-type="app"}). [Supplementary Table S5B](#app1-ijms-21-02741){ref-type="app"} lists the enrichments for the cellular component in this group.

2.5. Analysis of Unique Protein Interactions {#sec2dot5-ijms-21-02741}
--------------------------------------------

We also explored in STRING whether these unique proteins have functional interactions among each other. The statistical background assumed for this enrichment analysis was the whole human genome. We filtered our search for established interactions only for the input proteins, for the highest confidence (over 0.900), and for a static map without the protein structures. In the obtained interaction maps, different nodes are connected with colored lines depending on the functional association type. The results imply that the identified proteins have more interactions among themselves than what would be expected for a random set of proteins of similar size, drawn from the genome. Such enrichments indicate that the proteins are, at least partially, biologically connected as a group and may contribute jointly to shared functions.

The interactions of the 112 unique surface proteins in the control group as compared to the HIV group are illustrated in [Figure 3](#ijms-21-02741-f003){ref-type="fig"}A. The HIV group in this comparison had only three unique surface proteins (DNAH8, TTN, and IGHG2). Being present on the EV surface, these proteins may be prone to interact with their potential functional partners beyond the EV surface. Therefore, we examined their possible interactions not only with each other but with other proteins as well. The STRING program identified predicted functional partners for DNAH8 and TTN, and the top five candidates that were predicted with the highest confidence, as well as their interacting networks, are illustrated in [Figure 3](#ijms-21-02741-f003){ref-type="fig"}B.

Next, we evaluated the unique surface protein list in the HIV vs. HIV+Aβ group. No protein--protein interactions were found for the six proteins uniquely expressed in the HIV group. By contrast, the HIV+Aβ unique surface proteins had several complex interactions, as illustrated in [Figure 3](#ijms-21-02741-f003){ref-type="fig"}C.

Finally, we analyzed the interactions between the unique proteins present in the total HBMEC-EV proteome. No interactions were found in the control group as compared to the HIV group; however, the elaborate interaction map for the total unique proteins in the HIV group is presented in [Figure 4](#ijms-21-02741-f004){ref-type="fig"}A. For the HIV vs. HIV+Aβ comparison, the HIV group exhibited 28 unique proteins without any identified interactions. In contrast, the unique proteins in the HIV+Aβ group showed a complicated interaction network, as illustrated in [Figure 4](#ijms-21-02741-f004){ref-type="fig"}B.

3. Discussion {#sec3-ijms-21-02741}
=============

In the current study, we evaluated HBMEC-EV surface and total proteome changes evoked by HIV-1 alone and together with Aβ. We limited our analyses to the unique lists of proteins identified in the treatment groups; thus, we did not include the shared protein lists and the complex changes in the up- and down-regulated proteins. In addition, we specifically focused on the unique proteins in the control vs. HIV and in the HIV vs. HIV+Aβ group comparisons. The identified proteins were mapped to different gene ontology (GO) terms for biological processes, KEGG pathways, and Cell Components. We also explored the protein--protein interactions among the identified unique proteins.

Overall, the surface proteome control vs. HIV comparison indicated that the functions of the identified unique proteins ranged from diverse biological processes in the control (mainly "extracellular matrix organization," "metabolic processes," "vesicle-mediated transport," "exocytosis") and KEGG pathways (mainly "proteoglycans in cancer," "focal adhesion," "carbohydrate and cholesterol metabolism," "HIF-1 signaling pathway") to few or no distinct biological processes in the HIV group ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}A and [Table 4](#ijms-21-02741-t004){ref-type="table"}). The latter phenomenon was likely due to the limited number of proteins (namely, DNAH8, TTN, IGHG2) that were unique in the HIV-1 group when compared to the HBMEC-EV surface proteome of the controls. Nevertheless, we found several potential functional partners for DNAH8, such as platelet-activating factor acetylhydrolase IB subunit alpha (PAFAH1B1), dynactin subunit 1 (DCTN1), dynactin subunit 2 (DCTN2), CAP-Gly domain-containing linker protein 1 (CLIP1), and cytoplasmic dynein 1 light intermediate chain 1 (DYNC1LI1). Similarly, we identified several predicted functional partners for TTN, namely, nebulin (NEB), telethonin (TCAP), troponin C, skeletal muscle (TNNC2), myosin light chain 1/3, skeletal muscle isoform (MYL1), and alpha-actinin-2 (ACTN2) ([Figure 3](#ijms-21-02741-f003){ref-type="fig"}B). Thus, these few unique surface EV proteins in the HIV group may engage primarily with proteins of actin cytoskeleton/microtubule remodeling and vesicle-mediated transport.

The control EV proteome exhibited more than a hundred unique proteins; thus, it appears that after HIV-1 exposure of the parent cells, the EV surface proteome almost completely "blended" into the control proteome. This relative lack of surface HBMEC-EV protein signature in the HIV group is particularly striking in light of our previous findings where the exposure of HBMEC to HIV results in increased EV shedding \[[@B18-ijms-21-02741]\] and the fact that EVs are involved in spreading HIV infection to the neighboring cells. However, it is possible that the localization of some proteins could alter from the EV surface to the vesicle lumen, resulting in a highly enriched total but not surface proteome. Indeed, comparison of the total proteome revealed a highly diverse number of 259 unique proteins in the HIV group as compared to the control that mapped to a variety of biological processes and KEGG pathways. The most prominent enrichment among the biological processes category was "vesicle-mediated transport," followed by "extracellular structure organization." In addition, mapping these unique proteins to "exocytosis" and "secretion by cell" categories points to processes that may be involved in EV release and EV transport ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}B and [Table 8](#ijms-21-02741-t008){ref-type="table"}). Likewise, the KEGG pathways were also diverse, from "focal adhesion" and "endothelial cell medium (ECM)-receptor interaction" to "proteoglycans in cancer," different infections, "endocytosis," "cholesterol metabolism," and "glycolysis/gluconeogenesis" ([Table 8](#ijms-21-02741-t008){ref-type="table"}). Thus, the total EV proteome in the HIV group, with a large number of unique proteins, may suggest that the rich, unique cargo is somewhat "hidden" within the EVs with a surface proteome that was barely altered. This notion is supported by the observations that the HIV group in the HIV versus HIV+Aβ group surface proteome comparison also exhibited only six unique proteins ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}C). On the other hand, the relative lack of unique EV surface protein signatures may facilitate EV internalization and, thus, HIV transmission to other cells.

In addition to the effects of HIV-1, we explored the impact of Aβ on the HBMEC-EV proteome in the context of HIV-1. It was reported that increased brain Aβ induced profound proteome remodeling in multiple cell types, altering brain molecular pathways in an Alzheimer's disease (AD) mouse model \[[@B24-ijms-21-02741]\]. Another brain proteomic study using a different AD mouse model with amyloid and neurofibrillary tangle pathologies indicated age-dependent immune responses and synaptic dysfunctions. It was proposed that these changes were evoked by the advancing Aβ pathology in the brain \[[@B25-ijms-21-02741]\], further demonstrating the importance of proteomic analyses in studies on the mechanisms of amyloid pathology.

Comparison of surface proteomes of EVs derived from HBMEC exposed to HIV alone vs. HIV+Aβ revealed profound changes, as demonstrated by 116 unique proteins in the HIV+Aβ group ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}C). Aβ, acting on a HIV background, appeared to shift biological processes from mainly actin cytoskeleton organization ([Table 5](#ijms-21-02741-t005){ref-type="table"}) to immune responses, extracellular matrix organization, and carbohydrate metabolic processes. In addition, enrichment of the "vesicle-mediated transport" and "exocytosis" also pointed to processes involved in EV release and EV transport ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}C and [Table 6](#ijms-21-02741-t006){ref-type="table"}). The KEGG pathways changed from a "blended" profile in the HIV group to a very diverse profile in the HIV+Aβ group, pointing mainly to the carbohydrate metabolic processes, "focal adhesion," different infections, and signaling pathways as demonstrated by HIF-1, MAPK, and AGE-RAGE enrichment ([Table 6](#ijms-21-02741-t006){ref-type="table"}). Regarding these signaling pathways, we have shown before the involvement of the RAGE pathway in the HIV-induced Aβ accumulation in HBMEC \[[@B26-ijms-21-02741]\].

The HIV vs. HIV+Aβ comparison for the total proteome indicated substantial remodeling in the HIV+Aβ with 201 unique proteins as compared to 28 of such proteins in the HIV group. Consistent with HIV+Aβ-mediated EV release \[[@B18-ijms-21-02741]\], the biological processes changed from "cell envelope organization" ([Table 9](#ijms-21-02741-t009){ref-type="table"}) to mainly "vesicle-mediated transport," "exocytosis," and immune responses ([Figure 2](#ijms-21-02741-f002){ref-type="fig"}D and [Table 10](#ijms-21-02741-t010){ref-type="table"}). The KEGG pathways also shifted to a diverse profile. "Endocytosis" was the most significant, followed by "focal adhesion" and "bacterial invasion of epithelial cells." Several proteins were part of the carbohydrate metabolic pathways, such as the "pentose phosphate pathway," "starch and sucrose metabolism," and "proteoglycans in cancer" ([Table 10](#ijms-21-02741-t010){ref-type="table"}).

Surprisingly, surface and total proteome analysis across different groups did not find any Aβ species in EVs, not even in samples that were isolated from Aβ-exposed HBMEC. This lack of Aβ identification could be related to technical issues, such as aggregation of Aβ, its insolubility, and possibly indigestibility by trypsin. The tryptic peptide used to quantify β-amyloid, LVFFAEDVGSNK, corresponding to amino acids 688--699, maps to all species of Aβ and full-length APP \[[@B27-ijms-21-02741]\] and has been identified in the human CSF proteome \[[@B28-ijms-21-02741]\]. In our study, no peptides mapping to the Aβ-generating region of APP were identified, even though APP was identified on the surface proteome. Similar obstacles were described in another proteomic study, in which Aβ was not identified in human AD brains. However, Aβ was detected by dot blot and ELISA from the same samples \[[@B29-ijms-21-02741]\], supporting the notion that the lack of Aβ detection in the proteome was likely due to technical limitations.

Our previous studies demonstrated that treatment of HBMEC with Aβ could enrich EVs with this peptide, which can then be carried and delivered to different cells of the neurovascular unit \[[@B18-ijms-21-02741],[@B30-ijms-21-02741]\]. In support of these findings, literature reports described Aβ as being present on the EV surface. For example, neuron-derived EVs accelerated Aβ fibril formation from monomeric Aβ, and this process was inhibited by cleavage of glycosphingolipid (GSL) glycans by endoglycoceramidase (EGCase) \[[@B31-ijms-21-02741]\]. The same group also demonstrated that EV GSL-glycans were critical for Aβ binding in vitro and in vivo \[[@B15-ijms-21-02741]\]. GSLs are found mainly in lipid rafts in the outer layer plasma membrane with their glycans facing outside; however, they are more abundant in EVs than in the parent cells \[[@B15-ijms-21-02741]\]. Besides GSL, EVs were shown to bind Aβ through the prion protein (PrP) \[[@B14-ijms-21-02741]\], a glycosylphosphatidylinositol-anchored protein in the outer leaflet of the neuron and neuron-derived EV membrane \[[@B32-ijms-21-02741]\].

Some of the unique proteins identified in our HBMEC-derived EVs exhibit a substantial overlap with proteins detected by label-free proteomics in Aβ-enriched extracts from human AD brains \[[@B29-ijms-21-02741]\], suggesting the relevance of EV proteins to Aβ pathology. The examples include ANXA5, FGB, LAMA5, and VIM found both in the total proteome of EVs in the HIV group and in Aβ-enriched extracts from human AD brains \[[@B29-ijms-21-02741]\]. In addition, specific types of tubulins, such as TUBA1B and TUBB4B, were present, although they did not change in AD brains. Among the unique proteins in the HIV+Aβ group's total proteome, FGG and HIST1H2BK, as well as tubulins TUBB and TUBB2A, were also enriched in extracts from AD brains \[[@B29-ijms-21-02741]\]. In addition, HIST1H2BK has been one of the unique proteins in the EV total proteome from the Aβ group. In contrast, RNF213 was not identified in any of our EV samples, although it was unique to the AD brain samples and also found within the amyloid plaques \[[@B29-ijms-21-02741]\]. One explanation for this phenomenon could be that RNF213 in the AD brain might not originate from brain endothelial cells.

Analysis for predicted significant functional interactions among the unique proteins produced several elaborate interaction maps ([Figure 3](#ijms-21-02741-f003){ref-type="fig"} and [Figure 4](#ijms-21-02741-f004){ref-type="fig"}). It is striking to notice that several proteins on these maps act like "hubs" or centers by having a substantial number of connections to other proteins. Such "hubs" for the surface proteomes were SERPINE1 (PAI-1), GPC1, FERMT3 ([Figure 3](#ijms-21-02741-f003){ref-type="fig"}A), and ALDOA ([Figure 3](#ijms-21-02741-f003){ref-type="fig"}C). The most complex functional interaction maps were obtained for the total proteomes due to the high number of unique proteins. The identified "hubs" were RAC1, GAS6, SERPINE1, AGRN, APOB, and RAB5C ([Figure 4](#ijms-21-02741-f004){ref-type="fig"}A), as well as CDC42 and RAB1A ([Figure 4](#ijms-21-02741-f004){ref-type="fig"}B). Among these proteins, endothelial AGRN (agrin) was shown to be implicated in the brain Aβ pathology. For example, deletion of the *Agrn* gene from endothelial cells resulted in significantly increased Aβ levels in the mouse brain; however, overexpression of *Agrn* restored brain Aβ levels \[[@B33-ijms-21-02741]\]. SERPINE1 (PAI-1) and GPC1 (glypican-1) may be additional important players in the Aβ pathology \[[@B34-ijms-21-02741],[@B35-ijms-21-02741]\]. Indeed, GPC1, a heparan sulfate proteoglycan, localized mainly in detergent-insoluble, GSL-rich membrane domains, was shown to bind fibrillar Aβ in the human brain \[[@B36-ijms-21-02741]\], further suggesting that protein "hubs" identified in the present study may be involved in EV-mediated Aβ pathology.

In summary, our results provide information, with an unprecedented resolution, on the brain endothelial surface and total EV proteome changes after HIV and Aβ exposure of the parent cells. The analyses identified protein--protein interaction networks, biological processes, pathways, and cellular localization. Overall, the obtained results factor for a better understanding of HBMEC-EV protein landscape changes induced by HIV and Aβ and their contribution to the HIV-associated Aβ pathology in the brain.

4. Materials and Methods {#sec4-ijms-21-02741}
========================

4.1. Cell Cultures {#sec4dot1-ijms-21-02741}
------------------

*Primary human brain microvascular endothelial cells (HBMEC)* used in the study were purchased from ScienCell Research laboratories (Carlsbad, CA, USA). HBMEC were isolated from human brain and cryopreserved at passage one. HBMEC were characterized by immunofluorescence with antibodies specific to vWF/Factor VIII and CD31 (PECAM). Cells were cultured on bovine plasma fibronectin (ScienCell)-coated dishes in endothelial cell medium (ECM). Specifically, 500 mL of basal ECM medium was supplemented with 25 mL of exosome-depleted fetal bovine serum (Exo-FBS; System Biosciences, Mountain View, CA, USA), 5 mL of endothelial cell growth supplement (ECGS, ScienCell), and 5 mL of penicillin/streptomycin solution (P/S, ScienCell). We initiated two separate cultures on 100 mm cell culture dishes to reduce the number of passages and subcultured the cells twice at the 1:4 ratio. This resulted in 32 confluent cultures, with the average cell number at the end of experiment of 9.065 × 10^7^ cells/dish. Sixteen confluent cultures were used for EV surface proteomics, and 16 for EV total proteomics. The treatment groups were: 1) Control exposed to vehicle, 2) Aβ alone, 3) HIV alone, 4) HIV plus Aβ, with four samples/group.

4.2. HIV Infection and Aβ Treatment {#sec4dot2-ijms-21-02741}
-----------------------------------

HIV-1 stock was generated using human embryonic kidney (HEK) 293T cells (ATCC, Manassas, VA, USA) transfected with pYK-JRCSF plasmid containing full-length proviral DNA. Throughout the study, HBMEC were exposed to HIV particles at the p24 level of 30 ng/mL as previously reported \[[@B37-ijms-21-02741]\]. Treatment was terminated by removing the cell culture media for EV isolation.

Aβ (1--40) was purchased from Anaspec (San Jose, CA, USA) and dissolved in PBS. Freshly solubilized Aβ solutions without pre-aggregation were used for experiments as such a form of Aβ was demonstrated to induce proinflammatory reactions in isolated rat brain microvessels \[[@B38-ijms-21-02741]\]. Cells were treated with Aβ (1--40) at the concentration of 100 nM for 48 h in complete medium. Although uptake of Aβ by the BBB occurs rapidly \[[@B39-ijms-21-02741]\], we terminated the treatment at 48 h to allow more EV to be secreted into the culture medium. Confluent HBMEC were exposed to HIV-1 or/and Aβ (1--40) for 48 h.

4.3. EV Isolation {#sec4dot3-ijms-21-02741}
-----------------

EV isolation was performed using ExoQuick-TC precipitation solution (System Biosciences) from conditioned culture media according to the manufacturer's specifications. Briefly, 10 mL culture media from confluent HBMEC cultures was centrifuged at 3000 g for 15 min to remove cells and debris, and then mixed thoroughly with 2 mL of Exo-Quick precipitation solution and incubated overnight at 4 °C. The next day, samples were centrifuged at 1500 g for 30 min, and the supernatants were removed and centrifuged again at 1500 g for 5 min. The EV pellets were stored at --80 °C and used for proteomics analysis. Separate EV samples were prepared for EV surface and total proteomics.

4.4. Proteomics {#sec4dot4-ijms-21-02741}
---------------

*Sample Preparation.* Each sample was processed by SDS-PAGE using a 10% Bis Tris NuPage mini-gel (Invitrogen, Waltham, MA, USA) in the MES buffer system. The migration windows (1 cm lane) were excised and processed by in-gel digestion with trypsin using a ProGest robot (DigiLab) with the following protocol: The samples were washed with 25 mM ammonium bicarbonate followed by acetonitrile, reduced with 10 mM dithiothreitol at 60 °C, followed by alkylation with 50 mM iodoacetamide at room temperature, digested with trypsin (Promega, Madison, WI, USA) at 37 °C for 4 h, and quenched with formic acid. The supernatants were then analyzed directly without further processing.

*Mass Spectrometry.* Half of each digested sample was analyzed by nano LC-MS/MS with a Waters NanoAcquity HPLC system interfaced to a ThermoFisher Q Exactive. Peptides were loaded on a trapping column and eluted over a 75 μm analytical column at 350 nL/min; both columns were packed with Luna C18 resin (Phenomenex, Torrance, CA, USA). The mass spectrometer was operated in data-dependent mode, with the Orbitrap operating at 70,000 FWHM and 17,500 FWHM for MS and MS/MS respectively. The fifteen most abundant ions were selected for MS/MS.

*Data Processing.* Data were searched using Mascot (Matrix Science, London, UK; version 2.6.0) with the following parameters: Enzyme: Trypsin/P; Databases: SwissProt Human (concatenated forward and reverse plus common contaminants); fixed modifications: Carbamidomethyl (C); variable modifications: Acetyl (N-term), deamidation (N,Q), oxidation (M), Pyro-Glu (N-term Q); mass values: Monoisotopic; peptide mass tolerance: 10 ppm; fragment mass tolerance: 0.02 Da; max missed cleavages: 2. Mascot DAT files were parsed into Scaffold (Proteome Software, version Scaffold 4.8.7, Proteome Software Inc., Portland, OR, USA) for validation, filtering, and to create a non-redundant list per sample. Data were filtered using a 1% protein and peptide FDR and required at least two unique peptides per protein. Protein probabilities were assigned by the Protein Prophet algorithm \[[@B40-ijms-21-02741]\]. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony. Proteins were annotated with GO terms from NCBI (downloaded on Sep 6, 2018) \[[@B41-ijms-21-02741]\]. The normalized spectral abundance factor (NSAF) calculation contains the conversion to the spectral abundance factor (SAF) and subsequent normalized spectral abundance factor (NSAF). This was based on the equation: NSAF = (SpC/MW)/Σ(SpC/MW)N, where SpC = spectral counts, MW = protein molecular weight in kDa, and N = total number of proteins. NSAF values can be used to approximate the relative abundance of proteins within a given sample and the relative abundance of a given protein between samples. The different treatment groups were compared using the *t*-test, and *p* \< 0.05 was considered significant.

4.5. ExoCarta Database Search and Functional Enrichment Analysis {#sec4dot5-ijms-21-02741}
----------------------------------------------------------------

The list of the top 100 proteins most often identified in EVs was composed based on the ExoCarta EV proteomics database from different human cell types \[[@B19-ijms-21-02741]\]. Enrichment in molecular functions of the identified EV proteins was analyzed using the Scaffold Proteome Software and STRING \[[@B42-ijms-21-02741]\]. A gene ontology analysis study was carried out with the proteomic profiles obtained to identify overrepresentation profiles. Gene ontology was investigated at the levels of the biological process, KEGG pathways, and cell component. Textmining in STRING provided the most relevant publications for a particular enrichment. Kyoto Encyclopedia of Genes and Genomes (KEGG) established pathway maps representing molecular interactions, reactions, and relation networks for Metabolism, Genetic Information Processing, Environmental Information Processing, Cellular Processes, Organismal Systems, Human Diseases and Drug Development. KEGG PATHWAY is the reference database for pathway mapping in KEGG Mapper.

The following are available online at <https://www.mdpi.com/1422-0067/21/8/2741/s1>.

###### 

Click here for additional data file.
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Aβ

amyloid beta

AD

Alzheimer's disease

BBB

Blood--brain barrier

ECGS

Endothelial cell growth supplement

EV

Extracellular vesicle

ELISA

Enzyme-linked immunosorbent assay

HAND

HIV-associated neurocognitive disorders;

HBMEC

Human brain microvascular endothelial cells

HEK cells

Human embryonic kidney cells

HIV

Human immunodeficiency virus type 1

PBS

Phosphate buffered saline

PECAM

Platelet endothelial cell adhesion molecule

RAGE

Receptor for advanced glycation end products

###### 

Extracellular vesicle (EV)-specific markers in the surface and total proteomes of human brain microvascular endothelial cells (HBMEC)-derived EVs. Venn diagram showing the overlap between the HBMEC-EV surface proteome (283 proteins) (**A**) or the HBMEC-EV total proteome (501 proteins) (**B**) and the top 100 EV marker proteins from ExoCarta. Cellular component enrichment of the identified surface (**C**) and total (**D**) EV proteomes. The identified EV proteins were enriched for cellular component using the Scaffold software.
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###### 

Enrichment for biological processes of the identified unique EV proteins. Scaffold software was used to enrich for the main biological processes for the identified unique EV proteins. The upper Venn diagrams show the compared groups with the number of their unique and shared proteins. The lower pie charts depict the enriched biological processes corresponding to the unique lists highlighted in yellow. The number of proteins in a particular biological process category is also provided. (**A**) Surface proteome, control vs. HIV. (**B**) Total proteome, control vs. HIV. (**C**) Surface proteome, HIV vs. HIV+ amyloid beta (Aβ). (**D**) Total proteome, HIV vs. HIV+Aβ. Combined graph for the biological processes in the EV unique surface (**E**) and total (**F**) proteomes. The number of unique proteins corresponding to the main biological processes in the different comparisons is illustrated on the graph.
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###### 

Protein--protein interactions between the identified unique proteins of the EV surface proteome. Venn diagrams illustrating the type of comparison and the number of identified unique proteins (highlighted). (**A**) Protein--protein interactions (PPI) (STRING) among the unique surface proteins in the control group. Only interactions with the highest confidence are shown with a minimum required interaction score of 0.900 (PPI enrichment p-value: 6.59 × 10^−7^; the network has significantly more interactions than expected). Known interactions: From curated databases (turquoise), experimentally determined (pink); predicted interactions: Gene neighborhood (green), gene fusions (red), gene co-occurrence (blue); other interactions: Textmining (light green), co-expression (black), protein homology (purple). (**B**) No interactions with highest confidence were identified in STRING among the three unique proteins identified in the HIV group. Predicted functional partners of dynein heavy chain 8, axonemal (DNAH8) (upper map) and titin (TTN) (lower map). Only the first shell of five interactions with the highest confidence is shown. Color code of the interaction lines as described in (**A**). (**C**) Protein--protein interactions among the unique proteins in the HIV+Aβ group. Only interactions with the highest confidence are shown (PPI enrichment p-value: 0.00158; the network has significantly more interactions than expected). Color code of the interaction lines as described in (**A**).
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###### 

Protein--protein interactions in the identified unique proteins of the EV total proteome. Venn diagrams illustrating the type of comparison and the number of identified unique proteins (highlighted). (**A**) Protein--protein interactions among the unique proteins in the HIV group. Only interactions with the highest confidence are shown (PPI enrichment p-value: 1.0 × 10^−16^; the network has significantly more interactions than expected). (**B**) Protein--protein interactions among the unique proteins in the HIV+Aβ group. Only interactions with the highest confidence are shown (PPI enrichment p-value: 1.45 × 10^−7^; the network has significantly more interactions than expected). Color code of the interaction lines as described in [Figure 3](#ijms-21-02741-f003){ref-type="fig"}A.
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###### 

List of the top 100 ExoCarta proteins present in the brain endothelial extracellular vesicle (EV) surface (S) and total (T) proteome. Bold, top 100 ExoCarta proteins present in S or T; bold and red, proteins present in both S and T.

        Gene Symbol    Detected in S   Detected in T
  ----- -------------- --------------- ---------------
  1     **CD9**        −               \+
  2     **HSPA8**      \+              \+
  3     **PDCD6IP**    \+              \+
  4     **GAPDH**      \+              \+
  5     **ACTB**       \+              \+
  6     **ANXA2**      \+              \+
  7     **CD63**       −               \+
  8     **SDCBP**      \+              \+
  9     **ENO1**       \+              \+
  10    **HSP90AA1**   \+              \+
  11    **TSG101**     −               \+
  12    **PKM**        \+              \+
  13    **LDHA**       \+              \+
  14    **EEF1A1**     \+              \+
  15    **YWHAZ**      \+              \+
  16    **PGK1**       \+              \+
  17    **EEF2**       \+              \+
  18    **ALDOA**      \+              \+
  19    **HSP90AB1**   \+              \+
  20    **ANXA5**      \+              \+
  21    **FASN**       \+              \+
  22    **YWHAE**      \+              \+
  23    **CLTC**       \+              \+
  24    **CD81**       −               \+
  25    **ALB**        \+              \+
  26    **VCP**        \+              \+
  27    **TPI1**       \+              \+
  28    **PPIA**       \+              \+
  29    **MSN**        \+              \+
  30    **CFL1**       \+              \+
  31    **PRDX1**      \+              \+
  32    **PFN1**       \+              \+
  33    **RAP1B**      \+              \+
  34    **ITGB1**      \+              \+
  35    **HSPA5**      \+              \+
  36    **SLC3A2**     −               \+
  37    **HIST1H4A**   \+              \+
  38    GNB2           −               −
  39    **ATP1A1**     −               \+
  40    **YWHAQ**      \+              \+
  41    FLOT1          −               −
  42    **FLNA**       \+              \+
  43    **CLIC1**      \+              \+
  44    **CDC42**      \+              \+
  45    **CCT2**       \+              \+
  46    **A2M**        \+              \+
  47    **YWHAG**      \+              \+
  48    **TUBA1B**     \+              \+
  49    **RAC1**       −               \+
  50    **LGALS3BP**   \+              \+
  51    **HSPA1A**     \+              \+
  52    **GNAI2**      \+              \+
  53    **ANXA1**      \+              \+
  54    RHOA           −               −
  55    **MFGE8**      −               \+
  56    **PRDX2**      \+              −
  57    **GDI2**       \+              \+
  58    **EHD4**       −               \+
  59    **ACTN4**      \+              \+
  60    YWHAB          −               −
  61    **RAB7A**      −               \+
  62    **LDHB**       \+              \+
  63    GNAS           −               −
  64    TFRC           −               −
  65    **RAB5C**      −               \+
  66    ARF1           −               −
  67    **ANXA6**      \+              \+
  68    **ANXA11**     −               \+
  69    ACTG1          −               −
  70    **KPNB1**      \+              \+
  71    **EZR**        −               \+
  72    ANXA4          −               −
  73    **ACLY**       \+              \+
  74    TUBA1C         −               −
  75    **RAB14**      −               \+
  76    HIST2H4A       −               −
  77    **GNB1**       \+              \+
  78    **UBA1**       \+              \+
  79    **THBS1**      \+              \+
  80    **RAN**        \+              \+
  81    RAB5A          −               −
  82    **PTGFRN**     \+              \+
  83    **CCT5**       \+              \+
  84    **CCT3**       −               \+
  85    **BSG**        −               \+
  86    **AHCY**       \+              \+
  87    RAB5B          −               −
  88    **RAB1A**      −               \+
  89    **LAMP2**      −               \+
  90    ITGA6          −               −
  91    HIST1H4B       −               −
  92    **GSN**        \+              \+
  93    **FN1**        \+              \+
  94    **YWHAH**      −               \+
  95    **TUBA1A**     \+              −
  96    TKT            −               −
  97    **TCP1**       \+              \+
  98    **STOM**       −               \+
  99    SLC16A1        −               −
  100   RAB8A          −               −
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###### 

List of the unique proteins in the EV surface proteome.

  ----------------------------------------------------------------------------------
  Control vs. HIV   HIV vs. HIV+Aβ                                            
  ----------------- ---------------- ------- -------- -------- ------- ------ ------
  1433E             GPC6             TGM1    TITIN\   TITIN\   1433E   GPC1   TCPA
                                             DYH8\    NIN\                    
                                             IGHG2    DYH8\                   
                                                      CAP1\                   
                                                      ARPC4\                  
                                                      IGHG2                   

  1433G             GSTP1            TIG1    1433G    GPC6     TCPB           

  1433T             IGL1             TIMP3   1A34     GSTA5    TCPE           

  1A34              ITA3             TPM4    1B15     GSTP1    TCPH           

  5NTD              ITAV             TRFE    5NTD     HMCN1    TCPZ           

  6PGD              ITB1             TSP4    ACLY     IGL1     TIG1           

  ACLY              K2C6B            UBB     ACTC     IMB1     TPM4           

  ACTC              LAMA1            UGPA    ADA10    ITA3     TRFE           

  ALDOA             LCAT             URP2    AL9A1    ITA5     TSP4           

  AMPN              LDHA             VINC    ALDOA    ITAV     UBA1           

  AMY1              LDHB             WDR1    AMY1     ITB1     UBB            

  ANXA1             LOXL2            WNT5A   ANXA1    LDHA     UGPA           

  APOA4             LRC17                    ARF3     LDHB     URP2           

  ARF3              LRP1                     ARP2     LOXL2    VINC           

  ARGI1             LTBP1                    ARP3     LRC17    WDR1           

  ARP2              MIME                     ASPM     LRP1     WNT5A          

  ARP3              MMP2                     ATL1     LTBP1                   

  ATS13             MPRI                     ATX2     MIME                    

  C1S               MYL6                     B4GA1    MMP2                    

  CASPE             NID2                     C1S      NID2                    

  CCD80             P3H1                     CAZA1    P3H1                    

  CFAH              PAI1                     CCD80    PAI1                    

  CHIA              PCOC1                    CDC42    PDC6I                   

  CLIC1             PDC6I                    CHIA     PDIA3                   

  CO4A2             PDIA3                    CHSS2    PGK1                    

  CO5A2             PGK1                     CISY     PGM1                    

  CO7               PLEC                     CLIC1    PLEC                    

  CO7A1             PLOD3                    CLUS     PLOD3                   

  COBA1             PPIA                     CO4A2    PPIA                    

  COF1              PRDX4                    CO5A2    PRDX2                   

  COFA1             PYGB                     CO7A1    PRDX6                   

  COMP              RAB1B                    COBA1    PUR6                    

  EF1G              RACK1                    COF1     PYGB                    

  ENOB              RAP1B                    COFA1    PYGL                    

  EXT1              RLA0                     COMP     RACK1                   

  EXT2              RS16                     EF1G     RAP1B                   

  F13A              S10A9                    EXT1     RGN                     

  FA11              SDCB1                    F13A     RIMB1                   

  FAS               SEPR                     FA11     RL12                    

  FBLN1             SPB12                    FAS      S10A9                   

  FBN1              SPR1B                    FBLN1    SDCB1                   

  FBN2              SPR2E                    FBN1     SERA                    

  FLNB              SRCRL                    FBN2     SERPH                   

  FLNC              SRPX2                    FLNB     SPR2E                   

  FPRP              SULF1                    FLNC     SRCRL                   

  FRIH              SULF2                    FPRP     SRPX2                   

  FSCN1             SYTC                     FRIH     SULF1                   

  GAS6              TAGL2                    FRIL     SULF2                   

  GNAI2             TBA1A                    FSCN1    SYTC                    

  GPC1              TCPD                     GDIB     TAGL2                   
  ----------------------------------------------------------------------------------
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###### 

List of the unique proteins in the EV total proteome.

  -------------------------------------------------------------------------------
  Control vs. HIV                                                          
  -------------------- ------------------- ------- ------- ------- ------- ------
  ACTC\                1433T               CD81    GDIB    MVP     S10AB   URP2
  MYH1\                                                                    
  TAU                                                                      

  1433Z                CD82                GELS    MYH9    SAHH    VIME    

  1A24                 CLH1                GGCT    MYL6    SCRB2   VINC    

  5NTD                 CLIC1               GNAI2   MYOF    SDC4    VPS35   

  6PGD                 CO1A2               GPC6    NID1    SDCB1   VTNC    

  A4                   CO3A1               GRP78   NID2    SEPR    VWF     

  ACLY                 CO4A1               GSLG1   NNMT    SERPH   WDR1    

  ACTN1                CO4A2               GTR1    OLFL3   SND1    WNT5A   

  ACTN4                CO5                 H31     PAI1    SNED1   ZA2G    

  ADA10                CO5A1               H4      PDC6I   SPTB2           

  AEBP1                CO5A2               HEP2    PDIA3   SPTN1           

  AGRIN                CO6A2               HS90A   PFKAP   SRCRL           

  AHNK                 CO7A1               HS90B   PGK1    SRGN            

  ALDOA                CO9                 HSP7C   PGS1    SRPX            

  AMPN                 COEA1               HTRA1   PGS2    SRPX2           

  AMY1                 COFA1               IF4A1   PKP1    SULF1           

  ANT3                 COIA1               IGHA1   PLEC    SULF2           

  ANX11                COMP                ITA3    PLMN    SYDC            

  ANXA1                CYTA                ITA4    PLOD1   SYTC            

  ANXA5                DPYL2               ITA5    PLOD3   TAGL2           

  ANXA6                DYHC1               ITAV    PLS1    TBA1B           

  AP2A1                EF1A1               ITB1    PLS3    TBB4B           

  AP2M1                EF2                 ITIH1   PPIB    TCPA            

  APLP2                EHD1                ITIH3   PRC2A   TCPB            

  APOA4                EHD2                ITIH4   PRDX1   TCPD            

  APOB                 EMIL1               KLK7    PRDX6   TCPH            

  APOE                 ENOA                KPYM    PROF1   TCPQ            

  ARF3                 ENPL                LAMA1   PSB5    TCPZ            

  ARF4                 EXT1                LAMA2   PTX3    TENA            

  ARGI1                EXT2                LAMA4   PXDN    TERA            

  ARP2                 F13A                LAMA5   RAB5C   TGM1            

  ARPC2                FA5                 LAMP1   RAB7A   TGM2            

  AT1A1                FAS                 LAMP2   RAC1    TGM3            

  ATL1                 FAT1                LDHA    RACK1   THBG            

  ATS12                FBLN1               LDHB    RAN     THRB            

  ATS13                FBN1                LEG1    RAP1B   THY1            

  ATX2                 FBX50               LORI    RB11A   TIG1            

  B4GA1                FETA                LOXL2   RHOC    TITIN           

  BGH3                 FIBB                LRC17   RIMB1   TLN1            

  BMP1                 FILA                LRP1    RL10A   TPIS            

  C1QT3                FLNA                LTBP1   RL12    TPM4            

  C1S                  FLNB                LTBP2   RL13A   TRFE            

  CAP1                 FLNC                LYSC    RL27    TRFL            

  CASPE                FPRP                MAMC2   RL6     TSN14           

  CATA                 FSCN1               MARCS   RS16    TSP 1           

  CCD80                G3P                 MFGM    RS3     TSP 2           

  CD151                GALK1               MMP2    RS4X    TSP 3           

  CD44                 GAS6                MOES    RS8     TTYH3           

  CD59                 GBB1                MOT4    RSSA    UBA1            

  CD63                 GBG12               MRC2    S10A9   UBB             

  **HIV vs. HIV+Aβ**                                                       

  **HIV unique**       **HIV+Aβ unique**                                   

  AHNK                 1433E               CO8B    MIME    RL3             

  ARGI1                1433F               COF1    MOB1B   RL7             

  ATX2                 1433G               COPB2   MPRI    RL7A            

  B4GA1                1B40                COR1A   MRP     RLA0            

  CASPE                2AAA                COR1C   MXRA5   RS11            

  CATA                 4F2                 CTL1    MYH16   RS18            

  CYTA                 ACTC                CTL2    NDKA    RS2             

  FBX50                AK1A1               CTND1   NEP     RS20            

  FILA                 AL9A1               CYFP1   NIBL1   RS25            

  GGCT                 ALS                 DHX9    NOTC3   RS3A            

  HORN                 ANGL2               DSG4    NRP1    RS9             

  IGHA1                ANGL4               DX39B   OLM2B   RTN4            

  K1C13                ANM1                ECM1    P3H1    RUVB1           

  KLK7                 ANR31               ECM2    PAMR1   SC23A           

  LORI                 AP1G1               EEA1    PARVB   SCUB3           

  LYSC                 AP2B1               EF1G    PCOC1   SEM3C           

  MYOF                 APOM                EGLN    PDIA1   SEP11           

  PLS1                 ARF6                EHD4    PDIA6   SEPT2           

  PRC2A                ARP3                EIF3A   PDLI5   SERA            

  RIMB1                ARPC4               EZRI    PGFRB   SLIT2           

  RL27                 ASSY                FA10    PGM1    STOM            

  S10A9                AT1B3               FA11    PIP     SVEP1           

  SNED1                ATPA                FBN2    PLOD2   SYFB            

  SPB12                ATPB                FIBG    PP1B    SYHC            

  TGM1                 ATS7                FRIH    PPIA    SYK             

  TGM3                 B4GT5               G6PD    PRS23   SYRC            

  TITIN                BASI                G6PI    PRS8    SYSC            

  ZA2G                 BASP1               GANAB   PSA3    TARSH           

                       BGAL                H13     PSA6    TBB2A           

                       C1R                 H2A1    PSD11   TBB5            

                       C1TC                H2B1K   PSD12   TCPE            

                       CAD23               HGFL    PSD13   TCPG            

                       CALR                HHIP    PSMD1   TGFB1           

                       CAND1               HMCN1   PSMD2   TICN1           

                       CAPZB               HNRPK   PSMD3   TIE1            

                       CAV1                IGSF8   PUR6    TIMP3           

                       CAZA1               ILK     PYGB    TS101           

                       CBPN                IMB1    PYGL    TSN6            

                       CCBE1               IPO5    QSOX1   TSN9            

                       CD9                 IPO7    RAB10   TSP4            

                       CDC42               IQGA1   RAB14   UACA            

                       CEMIP               KCRM    RAB1A   UGDH            

                       CFAH                KR101   RAB2A   VAT1            

                       CHIA                KR111   RALA    VDAC1           

                       CHSS2               KRA11   RELN    VDAC2           

                       CISY                LAMB2   RGN     VGFR1           

                       CLUS                LIS1    RL14    XPO1            

                       CNTN1               LMNA    RL18    XPO2            

                       CO7                 LRC15   RL18A   XPP1            

                       CO8A                LUM     RL22    XRCC6           

                                                           XYLT1           
  -------------------------------------------------------------------------------
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###### 

Biological processes, KEGG pathways, and PMIDs for the EV surface unique proteins in the control group for the control vs. HIV comparison.

  ------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- --------- ---------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------
  **Gene Ontology (GO) Terms for Biological Processes**\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  **10 Most Significant Results per FDR (for all GO Terms, See [Supplemental Table S1A](#app1-ijms-21-02741){ref-type="app"})**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  **Term description**                                                                                                            **Obs**                                                                                                                                           **Bgr**   **FDR**          **Matching proteins in the network**                                                                                                                                                                                                                                                                

  Extracellular structure organization                                                                                            16                                                                                                                                                339       2.01 × 10^−10^   APOA4,COMP,FBLN1,FBN1,FBN2,GAS6,LAMA1,LCAT,LOXL2,MMP2,NID2,PLOD3,PRDX4,SERPINE1,SULF1,SULF2                                                                                                                                                                                                         

  Extracellular matrix organization                                                                                               14                                                                                                                                                296       4.25 × 10^−9^    COMP,FBLN1,FBN1,FBN2,GAS6,LAMA1,LOXL2,MMP2,NID2,PLOD3,PRDX4,SERPINE1,SULF1,SULF2                                                                                                                                                                                                                    

  Organonitrogen compound metabolic process                                                                                       42                                                                                                                                                5281      3.69 × 10 ^-6^   ACLY,AICDA,ALDOA,ANXA1,APOA4,C1S,CHIA,EEF1G,EXT1,EXT2,F13A1,FBLN1,FBN1,GAS6,GNB2L1,GPC1,GPC6,GSTP1,IGF2R,IGLL1,KRT1,LCAT,LDHA,LDHB,LEPRE1,LOXL2,LRP1,LTBP1,MMP2,MSRB1,PDIA3,PGD,PGK1,PLOD3,PPIA,PRDX4,RAB1B,SULF1,SULF2,TGM1,UBB,WNT5A                                                              

  Immune response                                                                                                                 22                                                                                                                                                1560      6.48 × 10^−6^    ACLY,ACTR3,AICDA,ALDOA,ANXA1,APOA4,C1S,CHIA,FAS,FLNB,GAS6,GSTP1,IGF2R,IGLL1,KRT1,LRP1,MSRB1,PPIA,PRDX4,PYGB,RAP1B,WNT5A                                                                                                                                                                             

  Vesicle-mediated transport                                                                                                      23                                                                                                                                                1699      6.48 × 10^−6^    ACLY,ACTR3,ALDOA,ANXA1,ARF3,F13A1,FERMT3,GAS6,GSTP1,IGF2R,IGLL1,KRT1,LOXL2,LRP1,PPIA,PRDX4,PYGB,RAB1B,RAP1B,SERPINE1,TIMP3,UBB,WDR1                                                                                                                                                                 

  Regulated exocytosis                                                                                                            15                                                                                                                                                691       6.48 × 10^−6^    ACLY,ALDOA,F13A1,FERMT3,GAS6,GSTP1,IGF2R,KRT1,PPIA,PRDX4,PYGB,RAP1B,SERPINE1,TIMP3,WDR1                                                                                                                                                                                                             

  Positive regulation of biological process                                                                                       42                                                                                                                                                5459      6.48 × 10^−6^    ACLY,ACTC1,ACTR3,AICDA,ANXA1,APOA4,C1S,CHIA,CLIC1,FAS,FBLN1,FBN1,FBN2,FERMT3,FSCN1,GAS6,GNAI2,GNB2L1,GPC1,GSTP1,IGF2R,IGLL1,KRT1,LDHA,LEPRE1,LOXL2,LRP1,MMP2,PDIA3,PPIA,RAB1B,RAP1B,SERPINE1,SRPX2,SULF1,SULF2,TGM1,THBS4,TIMP3,UBB,WDR1,WNT5A                                                      

  Anatomical structure development                                                                                                40                                                                                                                                                5085      6.48 × 10^−6^    ACTC1,AICDA,ANXA1,APOA4,COMP,EXT1,EXT2,FAS,FBLN1,FBN1,FBN2,FERMT3,FLNB,FLNC,FSCN1,GAS6,GNB2L1,GPC1,GSTP1,IGF2R,KRT1,LDHA,LEPRE1,LOXL2,LRP1,LTBP1,MMP2,MYL6,PGK1,PLOD3,PRDX4,RAP1B,SERPINE1,SRPX2,SULF1,SULF2,TGM1,UBB,WDR1,WNT5A                                                                    

  Response to stimulus                                                                                                            51                                                                                                                                                7824      6.48 × 10^−6^    ACLY,ACTC1,ACTR3,AICDA,ALDOA,ANXA1,APOA4,C1S,CHIA,CLIC1,EEF1G,EXT1,EXT2,F13A1,FAS,FBLN1,FBN1,FERMT3,FLNB,FSCN1,GAS6,GNAI2,GNB2L1,GPC1,GPC6,GPRC5A,GSTP1,IGF2R,IGLL1,KRT1,LAMA1,LDHA,LOXL2,LRP1,LTBP1,MMP2,MSRB1,PDIA3,PGK1,PLOD3,PPIA,PRDX4,PYGB,RAP1B,SERPINE1,SULF1,SULF2,THBS4,TIMP3,UBB,WNT5A   

  Positive regulation of cellular process                                                                                         39                                                                                                                                                4898      7.40 × 10^−6^    ACLY,ACTR3,AICDA,ANXA1,APOA4,CHIA,CLIC1,FAS,FBLN1,FBN1,FBN2,FERMT3,FSCN1,GAS6,GNAI2,GNB2L1,GPC1,GSTP1,IGF2R,IGLL1,LDHA,LEPRE1,LOXL2,LRP1,MMP2,PDIA3,PPIA,RAB1B,RAP1B,SERPINE1,SRPX2,SULF1,SULF2,TGM1,THBS4,TIMP3,UBB,WDR1,WNT5A                                                                     

  **KEGG Pathways**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  **Term Description**                                                                                                            **Obs**                                                                                                                                           **Bgr**   **FDR**          **Matching Proteins in the Network**                                                                                                                                                                                                                                                                

  Proteoglycans in cancer                                                                                                         7                                                                                                                                                 195       0.00093          FAS,FLNB,FLNC,GPC1,MMP2,TIMP3,WNT5A                                                                                                                                                                                                                                                                 

  Focal adhesion                                                                                                                  6                                                                                                                                                 197       0.0053           COMP,FLNB,FLNC,LAMA1,RAP1B,THBS4                                                                                                                                                                                                                                                                    

  Glycolysis / Gluconeogenesis                                                                                                    4                                                                                                                                                 68        0.0054           ALDOA,LDHA,LDHB,PGK1                                                                                                                                                                                                                                                                                

  HIF-1 signaling pathway                                                                                                         4                                                                                                                                                 98        0.0155           ALDOA,LDHA,PGK1,SERPINE1                                                                                                                                                                                                                                                                            

  Cholesterol metabolism                                                                                                          3                                                                                                                                                 48        0.0195           APOA4,LCAT,LRP1                                                                                                                                                                                                                                                                                     

  Malaria                                                                                                                         3                                                                                                                                                 47        0.0195           COMP,LRP1,THBS4                                                                                                                                                                                                                                                                                     

  **10 Most Significant PMID Publications per FDR**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  **Term ID**                                                                                                                     **Term Description**                                                                                                                              **Obs**   **Bgr**          **FDR**                                                                                                                                                                                                                                                                                             **Matching Proteins in the Network**

  PMID:21654676                                                                                                                   \(2011\) D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.                       8         62               1.79 × 10^−5^                                                                                                                                                                                                                                                                                       EXT1,EXT2,FAS,GPC1,GPC6,MMP2,SERPINE1,TIMP3

  PMID:22393382                                                                                                                   \(2012\) In vitro phenotypic, genomic and proteomic characterization of a cytokine-resistant murine Beta-TC3 cell line.                           7         42               2.32 × 10^−5^                                                                                                                                                                                                                                                                                       ALDOA,FAS,GSTP1,LDHA,LDHB,PDIA3,PRDX4

  PMID:25829250                                                                                                                   \(2015\) Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.                                        10        156              2.32 × 10^−5^                                                                                                                                                                                                                                                                                       EXT1,FBLN1,FBN1,GPC1,GPC6,MMP2,SULF1,SULF2,TIMP3,WNT5A

  PMID:26779482                                                                                                                   \(2015\) The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source.                                                               7         41               2.32 × 10^−5^                                                                                                                                                                                                                                                                                       FBLN1,FBN1,FBN2,LOXL2,LTBP1,PLOD3,SULF2

  PMID:23143224                                                                                                                   \(2013\) The biology of the extracellular matrix: Novel insights.                                                                                 6         28               5.53 × 10^−5^                                                                                                                                                                                                                                                                                       COMP,FBN1,FBN2,LTBP1,MMP2,TIMP3

  PMID:24223867                                                                                                                   \(2013\) Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro.           6         31               7.90 × 10^−5^                                                                                                                                                                                                                                                                                       COMP,LDHA,LDHB,MMP2,SERPINE1,THBS4

  PMID:26076122                                                                                                                   \(2015\) Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: Mechanisms and mysteries.                    6         31               7.90 × 10^−5^                                                                                                                                                                                                                                                                                       EXT1,EXT2,GPC1,GPC6,SULF1,SULF2

  PMID:20236620                                                                                                                   \(2010\) Unraveling the mechanism of elastic fiber assembly: The roles of short fibulins.                                                         6         33               8.27 × 10^−5^                                                                                                                                                                                                                                                                                       FBLN1,FBN1,FBN2,LOXL2,LTBP1,TIMP3

  PMID:20140087                                                                                                                   \(2010\) Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.                           8         103              8.31 × 10^−5^                                                                                                                                                                                                                                                                                       ALDOA,ANXA1,CLIC1,FLNB,FLNC,PDIA3,PGK1,PLEC

  PMID:27513329                                                                                                                   \(2016\) Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.   7         65               8.31 × 10^−5^                                                                                                                                                                                                                                                                                       COMP,FBLN1,FBN1,MMP2,NID2,SULF1,THBS4
  ------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- --------- ---------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------
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###### 

Biological processes and PMIDs for the EV surface unique proteins in the HIV group for the HIV vs. HIV+Aβ comparison.

  ------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------------- -------------------------------------- --------------------------------------
  **Gene Ontology (GO) Terms for Biological Processes**                                                                                                                                                                                                                                                                          
  **Term Description**                                    **Obs**                                                                                                                                                                                               **Bgr**   **FDR**         **Matching Proteins in the Network**   
  Cytoskeleton organization                               5                                                                                                                                                                                                     953       8.35 × 10^−5^   ARPC4,CAP1,DNAH8,NIN,TTN               
  Supramolecular fiber organization                       4                                                                                                                                                                                                     383       0.00011         ARPC4,CAP1,NIN,TTN                     
  Actin filament organization                             3                                                                                                                                                                                                     200       0.0011          ARPC4,CAP1,TTN                         
  Cellular protein-containing complex assembly            4                                                                                                                                                                                                     832       0.0012          ARPC4,DNAH8,NIN,TTN                    
  Actin polymerization or depolymerization                2                                                                                                                                                                                                     43        0.0031          ARPC4,CAP1                             
  Protein polymerization                                  2                                                                                                                                                                                                     83        0.0058          ARPC4,NIN                              
  Localization                                            5                                                                                                                                                                                                     5233      0.0296          ARPC4,CAP1,DNAH8,NIN,TTN               
  **PMID Publications**                                                                                                                                                                                                                                                                                                          
  **Term ID**                                             **Term Description**                                                                                                                                                                                  **Obs**   **Bgr**         **FDR**                                **Matching Proteins in the Network**
  PMID:21050039                                           \(2010\) Titin A-band-specific monoclonal antibody Tit1 5H1.1. Cellular Titin as a centriolar protein in non-muscle cells.                                                                            2         2               0.0016                                 NIN,TTN
  PMID:22985877                                           \(2012\) Epitope of titin A-band-specific monoclonal antibody Tit1 5 H1.1 is highly conserved in several Fn3 domains of the titin molecule. Centriole staining in human, mouse and zebrafish cells.   2         6               0.0037                                 NIN,TTN
  PMID:26655833                                           \(2016\) The centrosome is an actin-organizing centre.                                                                                                                                                2         12              0.0081                                 ARPC4,NIN
  PMID:27094867                                           \(2016\) Mutations in human C2CD3 cause skeletal dysplasia and provide new insights into phenotypic and cellular consequences of altered C2CD3 function.                                              2         27              0.027                                  NIN,TTN
  PMID:29255378                                           \(2017\) The human, F-actin-based cytoskeleton as a mutagen sensor.                                                                                                                                   2         35              0.0353                                 DNAH8,TTN
  ------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------------- -------------------------------------- --------------------------------------
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###### 

Biological processes, KEGG pathways, and PMIDs for the EV surface unique proteins in the HIV+Aβ group for the HIV vs. HIV+Aβ comparison.

  -------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------
  **Gene ontology (GO) Terms for Biological Processes**\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  **10 Most Significant Results per FDR (for All GO Terms, See [Supplementary Table S2A](#app1-ijms-21-02741){ref-type="app"})**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  **Term Description**                                                                                                             **Obs**                                                                                                                                                                    **Bgr**   **FDR**         **Matching Proteins in the Network**                                                                                                                                                                                                                                                               

  Immune effector process                                                                                                          18                                                                                                                                                                         927       9.47 × 10^−6^   ACLY,ACTR3,AICDA,ALDOA,C1S,CDC42,GSTP,IGLL1,KPNB1,KRT1,LRP1,PGM1,PPIA,PRDX6,PYGB,PYGL,RAP1B,WDR1                                                                                                                                                                                                   

  Leukocyte-mediated immunity                                                                                                      15                                                                                                                                                                         632       9.47 × 10^−6^   ACLY,AICDA,ALDOA,C1S,GSTP1,IGLL1,KPNB1,KRT1,PGM1,PPIA,PRDX6,PYGB,PYGL,RAP1B,WDR1                                                                                                                                                                                                                   

  Vesicle-mediated transport                                                                                                       23                                                                                                                                                                         1699      9.70 × 10^−6^   ACLY,ACTR3,ALDOA,ANXA1,ARF3,CDC42,F13A1,FERMT3,GSTP1,IGLL1,KPNB1,KRT1,LOXL2,LRP1,PGM1,PPIA,PRDX6,PYGB,PYGL,RAP1B,SERPINE1,UBB,WDR1                                                                                                                                                                 

  Extracellular matrix organization                                                                                                11                                                                                                                                                                         296       9.70 × 10^−6^   COMP,FBLN1,FBN1,FBN2,LOXL2,MMP2,NID2,PLOD3,SERPINE1,SULF1,SULF2                                                                                                                                                                                                                                    

  Regulated exocytosis                                                                                                             15                                                                                                                                                                         691       1.15 × 10^−5^   ACLY,ALDOA,F13A1,FERMT3,GSTP1,KPNB1,KRT1,PGM1,PPIA,PRDX6,PYGB,PYGL,RAP1B,SERPINE1,WDR1                                                                                                                                                                                                             

  Response to stimulus                                                                                                             51                                                                                                                                                                         7824      1.20 × 10^−5^   ACLY,ACTC1,ACTR3,AICDA,ALDOA,ANXA1,C1S,CDC42,CHIA,CLIC1,EEF1G,EXT1,F13A1,FAS,FBLN1,FBN1,FERMT3,FLNB,FSCN1,GNB2L1,GPC1,GPC6,GPRC5A,GSTP1,HMCN1,IGLL1,KPNB1,KRT1,LDHA,LOXL2,LRP1,LTBP1,MMP2,PDIA3,PGK1,PGM1,PHGDH,PLOD3,PPIA,PRDX2,PRDX6,PYGB,PYGL,RAP1B,SERPINE1,SULF1,SULF2,THBS4,UBA1,UBB,WNT5A   

  Negative regulation of cellular response to growth factor stimulus                                                               8                                                                                                                                                                          137       1.59 × 10^−5^   FBN1,FBN2,GPC1,LTBP1,SULF1,SULF2,UBB,WNT5A                                                                                                                                                                                                                                                         

  Immune system process                                                                                                            26                                                                                                                                                                         2370      2.26 × 10^−5^   ACLY,ACTR3,AICDA,ALDOA,ANXA1,C1S,CDC42,CHIA,FAS,FLNB,GPC1,GSTP1,IGLL1,KPNB1,KRT1,LRP1,PDIA3,PGM1,PPIA,PRDX6,PYGB,PYGL,RAP1B,UBB,WDR1,WNT5A                                                                                                                                                         

  Carbohydrate metabolic process                                                                                                   12                                                                                                                                                                         457       2.26 × 10^−5^   ALDOA,AMY1B,CHIA,EXT1,FBN1,LDHA,LDHB,PGK1,PGM1,PYGB,PYGL,RGN                                                                                                                                                                                                                                       

  Immune response                                                                                                                  21                                                                                                                                                                         1560      2.26 × 10^−5^   ACLY,ACTR3,AICDA,ALDOA,ANXA1,C1S,CHIA,FAS,FLNB,GSTP1,IGLL1,KPNB1,KRT1,LRP1,PGM1,PPIA,PRDX6,PYGB,PYGL,RAP1B,WNT5A                                                                                                                                                                                   

  **KEGG Pathways**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  **Term Description**                                                                                                             **Obs**                                                                                                                                                                    **Bgr**   **FDR**         **Matching Proteins in the Network**                                                                                                                                                                                                                                                               

  Glycolysis / Gluconeogenesis                                                                                                     5                                                                                                                                                                          68        0.00077         ALDOA,LDHA,LDHB,PGK1,PGM1                                                                                                                                                                                                                                                                          

  Proteoglycans in cancer                                                                                                          7                                                                                                                                                                          195       0.00077         CDC42,FAS,FLNB,FLNC,GPC1,MMP2,WNT5A                                                                                                                                                                                                                                                                

  Focal adhesion                                                                                                                   6                                                                                                                                                                          197       0.0035          CDC42,COMP,FLNB,FLNC,RAP1B,THBS4                                                                                                                                                                                                                                                                   

  Pentose phosphate pathway                                                                                                        3                                                                                                                                                                          30        0.0068          ALDOA,PGM1,RGN                                                                                                                                                                                                                                                                                     

  Starch and sucrose metabolism                                                                                                    3                                                                                                                                                                          33        0.0071          PGM1,PYGB,PYGL                                                                                                                                                                                                                                                                                     

  Metabolic pathways                                                                                                               13                                                                                                                                                                         1250      0.0095          ACLY,ALDOA,CHIA,EXT1,LDHA,LDHB,PGK1,PGM1,PHGDH,PRDX6,PYGB,PYGL,RGN                                                                                                                                                                                                                                 

  HIF-1 signaling pathway                                                                                                          4                                                                                                                                                                          98        0.0095          ALDOA,LDHA,PGK1,SERPINE1                                                                                                                                                                                                                                                                           

  Glucagon signaling pathway                                                                                                       4                                                                                                                                                                          100       0.0095          LDHA,LDHB,PYGB,PYGL                                                                                                                                                                                                                                                                                

  Malaria                                                                                                                          3                                                                                                                                                                          47        0.0104          COMP,LRP1,THBS4                                                                                                                                                                                                                                                                                    

  Carbon metabolism                                                                                                                4                                                                                                                                                                          116       0.011           ALDOA,PGK1,PHGDH,RGN                                                                                                                                                                                                                                                                               

  Fluid shear stress and atherosclerosis                                                                                           4                                                                                                                                                                          133       0.0164          GPC1,GSTA5,GSTP1,MMP2                                                                                                                                                                                                                                                                              

  Biosynthesis of amino acids                                                                                                      3                                                                                                                                                                          72        0.0233          ALDOA,PGK1,PHGDH                                                                                                                                                                                                                                                                                   

  Platinum drug resistance                                                                                                         3                                                                                                                                                                          70        0.0233          FAS,GSTA5,GSTP1                                                                                                                                                                                                                                                                                    

  Necroptosis                                                                                                                      4                                                                                                                                                                          155       0.0233          FAS,PPIA,PYGB,PYGL                                                                                                                                                                                                                                                                                 

  Complement and coagulation cascades                                                                                              3                                                                                                                                                                          78        0.0251          C1S,F13A1,SERPINE1                                                                                                                                                                                                                                                                                 

  Salmonella infection                                                                                                             3                                                                                                                                                                          84        0.0288          CDC42,FLNB,FLNC                                                                                                                                                                                                                                                                                    

  MAPK signaling pathway                                                                                                           5                                                                                                                                                                          293       0.0307          CDC42,FAS,FLNB,FLNC,RAP1B                                                                                                                                                                                                                                                                          

  AGE-RAGE signaling pathway in diabetic complications                                                                             3                                                                                                                                                                          98        0.0388          CDC42,MMP2,SERPINE1                                                                                                                                                                                                                                                                                

  Human papillomavirus infection                                                                                                   5                                                                                                                                                                          317       0.0388          CDC42,COMP,FAS,THBS4,WNT5A                                                                                                                                                                                                                                                                         

  Propanoate metabolism                                                                                                            2                                                                                                                                                                          32        0.0405          LDHA,LDHB                                                                                                                                                                                                                                                                                          

  Leukocyte transendothelial migration                                                                                             3                                                                                                                                                                          112       0.0476          CDC42,MMP2,RAP1B                                                                                                                                                                                                                                                                                   

  Primary immunodeficiency                                                                                                         2                                                                                                                                                                          37        0.0481          AICDA,IGLL1                                                                                                                                                                                                                                                                                        

  **10 Most Significant PMID Publications per FDR**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  **Term ID**                                                                                                                      **Term Description**                                                                                                                                                       **Obs**   **Bgr**         **FDR**                                                                                                                                                                                                                                                                                            **Matching Proteins in the Network**

  PMID:23823696                                                                                                                    \(2013\) Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy.   8         42              1.26 × 10^−6^                                                                                                                                                                                                                                                                                      ACLY,ALDOA,ANXA1,EEF1G,LDHB,PGM1,PPIA,PRDX2

  PMID:29250190                                                                                                                    \(2017\) Role of exosomes in hepatocellular carcinoma cell mobility alteration.                                                                                            7         34              8.40 × 10^−6^                                                                                                                                                                                                                                                                                      ANXA1,CLIC1,FBLN1,LRP1,PPIA,PYGB,PYGL

  PMID:20140087                                                                                                                    \(2010\) Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.                                                    9         103             9.47 × 10^−6^                                                                                                                                                                                                                                                                                      ALDOA,ANXA1,CLIC1,FLNB,FLNC,KPNB1,PDIA3,PGK1,PLEC

  PMID:29360750                                                                                                                    \(2018\) Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells.                                                        7         37              9.47 × 10^−6^                                                                                                                                                                                                                                                                                      ACLY,ANXA1,FBN1,FLNC,FSCN1,MMP2,PRDX2

  PMID:26779482                                                                                                                    \(2015\) The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source.                                                                                        7         41              1.08 × 10^−5^                                                                                                                                                                                                                                                                                      FBLN1,FBN1,FBN2,LOXL2,LTBP1,PLOD3,SULF2

  PMID:24142637                                                                                                                    \(2013\) Gastric autoantigenic proteins in Helicobacter pylori infection.                                                                                                  7         50              2.96 × 10^−5^                                                                                                                                                                                                                                                                                      ACTR3,GSTP1,LDHB,PDIA3,PRDX2,PRDX6,WDR1

  PMID:26184160                                                                                                                    \(2015\) A Review: Proteomics in Nasopharyngeal Carcinoma.                                                                                                                 8         83              2.96 × 10^−5^                                                                                                                                                                                                                                                                                      ANXA1,CLIC1,KRT1,MMP2,PPIA,PRDX2,PRDX6,SERPINE1

  PMID:26918450                                                                                                                    \(2016\) A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.                                                           8         89              3.71 × 10^−5^                                                                                                                                                                                                                                                                                      ACLY,CLIC1,GPC1,GPC6,LDHA,PGM1,PHGDH,WNT5A

  PMID:24223867                                                                                                                    \(2013\) Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro.                                    6         31              5.98 × 10^−5^                                                                                                                                                                                                                                                                                      COMP,LDHA,LDHB,MMP2,SERPINE1,THBS4

  PMID:20236620                                                                                                                    \(2010\) Unraveling the mechanism of elastic fiber assembly: The roles of short fibulins.                                                                                  6         33              7.46 × 10^−5^                                                                                                                                                                                                                                                                                      FBLN1,FBN1,FBN2,HMCN1,LOXL2,LTBP1
  -------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------
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###### 

PMIDs for the EV total unique proteins in the control group for the control vs. HIV comparison.

  ---------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------- --------- --------------------------------------
  **The 10 Most Significant PMID Publications According to FDR**                                                                                                                                                                                                                  
  **Term ID**                                                      **Term Description**                                                                                                                                                             **Obs**   **Bgr**   **FDR**   **Matching Proteins in the Network**
  PMID:19812696                                                    \(2009\) Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.                  3         154       0.0084    ACTC1,MAPT,MYH1
  PMID:20587776                                                    \(2010\) Mathematical modeling of endocytic actin patch kinetics in fission yeast: disassembly requires release of actin filament fragments.                                     2         12        0.0086    ACTC1,MYH1
  PMID:25275480                                                    \(2014\) Urethral dysfunction in female mice with estrogen receptor Beta deficiency.                                                                                             2         10        0.0086    ACTC1,MYH1
  PMID:22406440                                                    \(2012\) Deferiprone reduces amyloid-Beta and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.   2         15        0.0088    ACTC1,MAPT
  PMID:10931867                                                    \(2000\) Distinct families of Z-line targeting modules in the COOH-terminal region of nebulin.                                                                                   2         25        0.0099    ACTC1,MYH1
  PMID:11994316                                                    \(2002\) The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo.                                              2         26        0.0099    ACTC1,MYH1
  PMID:14557251                                                    \(2003\) Skeletal myosin heavy chain function in cultured lung myofibroblasts.                                                                                                   2         26        0.0099    ACTC1,MYH1
  PMID:17908293                                                    \(2007\) Identification of genes differentially expressed during prenatal development of skeletal muscle in two pig breeds differing in muscularity.                             2         52        0.0099    ACTC1,MYH1
  PMID:19291799                                                    \(2009\) Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.                                                                                   2         36        0.0099    MAPT,MYH1
  PMID:19325835                                                    \(2008\) Myosin assembly, maintenance and degradation in muscle: Role of the chaperone UNC-45 in myosin thick filament dynamics.                                                 2         44        0.0099    ACTC1,MYH1
  ---------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------- --------- --------------------------------------
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###### 

Biological processes, KEGG pathways, and PMIDs for the EV total unique proteins in the HIV group for the control vs. HIV comparison.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------ --------- ---------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------
  **Gene Ontology (GO) Terms for Biological Processes** **10 Most Significant Results per FDR (for All GO Terms, See [Supplementary Table S4A](#app1-ijms-21-02741){ref-type="app"})**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  **Term Description**                                                                                                                                                                   **Obs**                                                                                                                                                      **Bgr**   **FDR**          **Matching Proteins in the Network**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Vesicle-mediated transport                                                                                                                                                             57                                                                                                                                                           1699      1.02 × 10^−18^   ACLY,ACTN1,ACTN4,ALDOA,ANXA1,ANXA11,ANXA5,AP2A1,AP2M1,APLP2,APOB,APOE,ARF3,ARF4,ARPC2,CAP1,CD44,CD59,CD63,CD81,EEF2,EHD1,EHD2,F13A1,FERMT3,FLNA,GAS6,ITIH3,ITIH4,KRT1,LAMP1,LAMP2,LOXL2,LRP1,MFGE8,MRC2,MVP,MYH9,PKP1,PRDX6,PTX3,RAB5C,RAB7A,RAC1,RAP1B,SERPINE1,SPTBN1,SRGN,SRPX,TGM2,THBS1,TLN1,TTN,UBB,VPS35,VWF,WDR1                                                                                                                                                                                                                                                                                           
  Extracellular structure organization                                                                                                                                                   28                                                                                                                                                           339       7.06 × 10^−17^   AGRN,APOA4,APOB,APOE,BMP1,CD44,COMP,DCN,FBLN1,FBN1,GAS6,HTRA1,KLK7,LAMA1,LAMA2,LAMA4,LAMA5,LOXL2,MMP2,NID1,NID2,PLOD3,PXDN,SERPINE1,SULF1,SULF2,THBS1,VWF                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Platelet degranulation                                                                                                                                                                 20                                                                                                                                                           129       2.26 × 10^−16^   ACTN1,ACTN4,ALDOA,ANXA5,APLP2,CD63,F13A1,FERMT3,FLNA,GAS6,ITIH3,ITIH4,LAMP2,SERPINE1,SRGN,THBS1,TLN1,TTN,VWF,WDR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Regulated exocytosis                                                                                                                                                                   35                                                                                                                                                           691       1.19 × 10^−15^   ACLY,ACTN1,ACTN4,ALDOA,ANXA5,APLP2,CAP1,CD44,CD59,CD63,EEF2,F13A1,FERMT3,FLNA,GAS6,ITIH3,ITIH4,KRT1,LAMP1,LAMP2,MVP,PKP1,PRDX6,PTX3,RAB5C,RAB7A,RAC1,RAP1B,SERPINE1,SRGN,THBS1,TLN1,TTN,VWF,WDR1                                                                                                                                                                                                                                                                                                                                                                                                                   
  Extracellular matrix organization                                                                                                                                                      25                                                                                                                                                           296       2.14 × 10^−15^   AGRN,BMP1,CD44,COMP,DCN,FBLN1,FBN1,GAS6,HTRA1,KLK7,LAMA1,LAMA2,LAMA4,LAMA5,LOXL2,MMP2,NID1,NID2,PLOD3,PXDN,SERPINE1,SULF1,SULF2,THBS1,VWF                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Cellular component organization                                                                                                                                                        89                                                                                                                                                           5163      2.93 × 10^−14^   ACTN1,ACTN4,AGRN,ALDOA,ANXA1,ANXA6,AP2A1,AP2M1,APOA4,APOB,APOE,ARF4,ARPC2,ATL1,ATXN2,BMP1,CAP1,CD151,CD44,CD59,COMP,DCN,EHD1,EHD2,EXT1,FAS,FAT1,FBLN1,FBN1,FERMT3,FLNA,FLNB,FLNC,FSCN1,GAS6,GGCT,HIST1H4F,HTRA1,KLK7,KRT1,LAMA1,LAMA2,LAMA4,LAMA5,LAMP2,LOXL2,LTBP2,MFGE8,MMP2,MSRB1,MYH9,MYOF,NID1,NID2,PKP1,PLEC,PLOD3,PLS1,PLS3,PTGFRN,PXDN,RAB7A,RAC1,RAN,RHOC,SDC4,SEMG1,SERPINE1,SGCG,SLC25A6,SPAG1,SPTBN1,SRGN,SRPX,SULF1,SULF2,TGM1,TGM2,TGM3,THBS1,THY1,TLN1,TPM4,TTN,UBB,VPS35,VWF,WDR1,WNT5A                                                                                                            
  Secretion by cell                                                                                                                                                                      37                                                                                                                                                           959       2.43 × 10^−13^   ACLY,ACTN1,ACTN4,ALDOA,ANXA1,ANXA5,APLP2,CAP1,CD44,CD59,CD63,EEF2,F13A1,FERMT3,FLNA,GAS6,ITIH3,ITIH4,KRT1,LAMP1,LAMP2,LTBP2,MVP,PKP1,PRDX6,PTX3,RAB5C,RAB7A,RAC1,RAP1B,SERPINE1,SRGN,THBS1,TLN1,TTN,VWF,WDR1                                                                                                                                                                                                                                                                                                                                                                                                       
  Response to stimulus                                                                                                                                                                   107                                                                                                                                                          7824      6.96 × 10^−12^   ACLY,ACTN4,AFP,AGRN,AHCY,AICDA,ALDOA,ANXA1,ANXA11,ANXA5,ANXA6,AP2A1,AP2M1,APLP2,APOA4,APOB,APOE,ARF4,ARPC2,AZGP1,C1S,CAP1,CD151,CD44,CD59,CD63,CD81,CD82,CLIC1,DCN,EEF2,EHD1,EHD2,EXT1,EXT2,F13A1,FAS,FBLN1,FBN1,FERMT3,FLNA,FLNB,FSCN1,GAS6,GGCT,GNAI2,GNB2L1,GPC6,GPRC5A,HIST1H4F,HSPA5,ITIH4,KRT1,LAMA1,LAMA2,LAMA5,LAMP1,LAMP2,LDHA,LOXL2,LRP1,LTBP1,LTBP2,MMP2,MRC2,MSRB1,MVP,MYH9,MYOF,NNMT,PDIA3,PGK1,PKP1,PLOD1,PLOD3,POLR3G,PRDX1,PRDX6,PTX3,PXDN,RAB5C,RAB7A,RAC1,RAN,RAP1B,RHOC,SDC4,SEMG1,SERPINE1,SLC25A6,SPTBN1,SRGN,SRPX,STK33,SULF1,SULF2,TGM2,THBS1,THRB,THY1,TLN1,TTN,UBA1,UBB,VPS35,VWF,WNT5A   
  Localization                                                                                                                                                                           83                                                                                                                                                           5233      9.26 × 10^−11^   ACLY,ACTN1,ACTN4,AGRN,ALDOA,ANXA1,ANXA11,ANXA5,ANXA6,AP2A1,AP2M1,APLP2,APOA4,APOB,APOE,ARF3,ARF4,ARPC2,ATXN2,AZGP1,CAP1,CD151,CD44,CD59,CD63,CD81,CLIC1,EEF2,EHD1,EHD2,F13A1,FAT1,FBN1,FERMT3,FLNA,FLNB,FSCN1,GAS6,GPC6,HSPA5,ITIH3,ITIH4,KRT1,LAMA5,LAMP1,LAMP2,LOXL2,LRP1,LTBP1,LTBP2,MFGE8,MRC2,MVP,MYH9,PKP1,PLOD3,PLS1,PRDX6,PTX3,RAB5C,RAB7A,RAC1,RAN,RAP1B,RHOC,SDC4,SERPINE1,SLC25A6,SPTBN1,SRGN,SRPX,SRPX2,TGM2,THBS1,THY1,TLN1,TTN,TTYH3,UBB,VPS35,VWF,WDR1,WNT5A                                                                                                                                        
  Anatomical structure development                                                                                                                                                       80                                                                                                                                                           5085      5.90 × 10^−10^   ACTN1,AEBP1,AFP,AGRN,AICDA,ANXA1,AP2A1,APOA4,APOB,APOE,ARF4,ATL1,BMP1,C6orf58,CAP1,CD151,CD44,COMP,DCN,EEF2,EHD1,EXT1,EXT2,FAS,FAT1,FBLN1,FBN1,FERMT3,FLNA,FLNB,FLNC,FSCN1,GAS6,GNB2L1,HSPA5,HTRA1,KLK7,KRT1,LAMA2,LAMA5,LDHA,LOXL2,LRP1,LTBP1,MFGE8,MMP2,MYH9,MYL6,MYOF,NID1,NNMT,PGK1,PKP1,PLOD1,PLOD3,PLS3,PPIB,PRDX1,RAC1,RAP1B,RHOC,SDC4,SERPINE1,SGCG,SPTBN1,SRGN,SRPX2,SULF1,SULF2,TGM1,TGM2,TGM3,THBS1,THBS3,THRB,THY1,TTN,UBB,WDR1,WNT5A                                                                                                                                                                  
  **KEGG Pathways**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  **Term Description**                                                                                                                                                                   **Obs**                                                                                                                                                      **Bgr**   **FDR**          **Matching Proteins in the Network**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Focal adhesion                                                                                                                                                                         17                                                                                                                                                           197       1.23 × 10^−10^   ACTN1,ACTN4,COMP,FLNA,FLNB,FLNC,LAMA1,LAMA2,LAMA4,LAMA5,RAC1,RAP1B,THBS1,THBS2,THBS3,TLN1,VWF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  ECM-receptor interaction                                                                                                                                                               12                                                                                                                                                           81        5.47 × 10^−10^   AGRN,CD44,COMP,LAMA1,LAMA2,LAMA4,LAMA5,SDC4,THBS1,THBS2,THBS3,VWF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Proteoglycans in cancer                                                                                                                                                                12                                                                                                                                                           195       3.88 × 10^−6^    CD44,CD63,DCN,FAS,FLNA,FLNB,FLNC,MMP2,RAC1,SDC4,THBS1,WNT5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  Phagosome                                                                                                                                                                              10                                                                                                                                                           145       1.40 × 10^−5^    COMP,LAMP1,LAMP2,MRC2,RAB5C,RAB7A,RAC1,THBS1,THBS2,THBS3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Amoebiasis                                                                                                                                                                             8                                                                                                                                                            94        4.01 × 10^−5^    ACTN1,ACTN4,LAMA1,LAMA2,LAMA4,LAMA5,RAB5C,RAB7A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Malaria                                                                                                                                                                                6                                                                                                                                                            47        8.88 × 10^−5^    CD81,COMP,LRP1,THBS1,THBS2,THBS3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Salmonella infection                                                                                                                                                                   7                                                                                                                                                            84        0.00016          ARPC2,FLNA,FLNB,FLNC,MYH9,RAB7A,RAC1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Endocytosis                                                                                                                                                                            10                                                                                                                                                           242       0.00054          AP2A1,AP2M1,ARF3,ARPC2,EHD1,EHD2,RAB5C,RAB7A,UBB,VPS35                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Leukocyte transendothelial migration                                                                                                                                                   7                                                                                                                                                            112       0.0007           ACTN1,ACTN4,GNAI2,MMP2,RAC1,RAP1B,THY1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Human papillomavirus infection                                                                                                                                                         11                                                                                                                                                           317       0.00079          COMP,FAS,LAMA1,LAMA2,LAMA4,LAMA5,THBS1,THBS2,THBS3,VWF,WNT5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  PI3K-Akt signaling pathway                                                                                                                                                             10                                                                                                                                                           348       0.0069           COMP,LAMA1,LAMA2,LAMA4,LAMA5,RAC1,THBS1,THBS2,THBS3,VWF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Complement and coagulation cascades                                                                                                                                                    5                                                                                                                                                            78        0.0069           C1S,CD59,F13A1,SERPINE1,VWF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  Cholesterol metabolism                                                                                                                                                                 4                                                                                                                                                            48        0.0088           APOA4,APOB,APOE,LRP1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Toxoplasmosis                                                                                                                                                                          5                                                                                                                                                            109       0.0226           GNAI2,LAMA1,LAMA2,LAMA4,LAMA5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Glycolysis / Gluconeogenesis                                                                                                                                                           4                                                                                                                                                            68        0.0259           ALDOA,LDHA,LDHB,PGK1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  p53 signaling pathway                                                                                                                                                                  4                                                                                                                                                            68        0.0259           CD82,FAS,SERPINE1,THBS1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Platelet activation                                                                                                                                                                    5                                                                                                                                                            123       0.0308           FERMT3,GNAI2,RAP1B,TLN1,VWF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  **10 Most Significant PMID Publications per FDR**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  **Term ID**                                                                                                                                                                            **Term Description**                                                                                                                                         **Obs**   **Bgr**          **FDR**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            **Matching Proteins in the Network**
  PMID:29250190                                                                                                                                                                          \(2017\) Role of exosomes in hepatocellular carcinoma cell mobility alteration.                                                                              17        34               1.84 × 10^−18^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ACTN1,ANXA1,ANXA11,ANXA5,ANXA6,APOB,APOE,CAP1,CLIC1,FBLN1,FLNA,ITIH4,LRP1,MFGE8,NID1,RAN,TLN1
  PMID:24009881                                                                                                                                                                          \(2012\) Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.                                21        161              9.74 × 10^−14^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     AHCY,ANXA1,ANXA11,ANXA5,ANXA6,ARF3,ARPC2,CD44,CD63,CD81,FSCN1,KRT1,LAMP1,MFGE8,MYH9,MYL6,PGK1,PTGFRN,RAB5C,RAB7A,VPS35
  PMID:19948009                                                                                                                                                                          \(2009\) Proteomic analysis of blastema formation in regenerating axolotl limbs.                                                                             22        221              1.76 × 10^−12^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ANXA1,ANXA11,ANXA5,ANXA6,DCN,EEF2,FBN1,FLNB,GNB2L1,MVP,MYH9,MYL6,MYOF,PDIA3,PLS3,PRDX1,PXDN,RAN,SND1,TTN,UBA1,WNT5A
  PMID:24392111                                                                                                                                                                          \(2014\) Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: a new paradigm for myoblast-myotube cross talk?                             16        79               1.87 × 10^−12^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ALDOA,ANXA5,CD44,CD63,CD81,CD82,EEF2,FLNC,LAMP1,LAMP2,LDHA,MYOF,PGK1,TLN1,TTN,VPS35
  PMID:27605433                                                                                                                                                                          \(2016\) Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.                                                           17        107              5.36 × 10^−12^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ACLY,ANXA1,ANXA6,CD44,CD63,CD81,CD82,FAT1,GNB2L1,LAMA1,LAMP1,MFGE8,MMP2,PLS3,SULF1,THBS1,VPS35
  PMID:22897585                                                                                                                                                                          \(2012\) Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MSMS analysis.   13        42               1.24 × 10^−11^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     AGRN,ANXA1,ANXA11,ANXA5,ANXA6,CD44,DCN,FBN1,LAMA1,LAMA2,LAMA4,LAMA5,VWF
  PMID:27770278                                                                                                                                                                          \(2017\) Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.                     14        63               3.75 × 10^−11^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ACTN4,ANXA1,CCT6A,CD44,EHD1,HSPA5,LAMA4,MMP2,MVP,MYH9,RAB5C,RAB7A,UBA1,VPS35
  PMID:22159717                                                                                                                                                                          \(2012\) The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.                          14        64               3.97 × 10^−11^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     AGRN,ANXA1,ANXA11,ANXA5,ANXA6,DCN,FBN1,LOXL2,LTBP2,NID1,NID2,SRPX,THBS1,VWF
  PMID:25201077                                                                                                                                                                          \(2015\) Proteomics of apheresis platelet supernatants during routine storage: Gender-related differences.                                                   16        106              5.20 × 10^−-11^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ACTN1,APOB,APOE,ARPC2,C1S,FERMT3,FLNA,ITIH4,LDHA,MMP2,MYL6,PRDX6,SRGN,THBS1,TLN1,VWF
  PMID:28071719                                                                                                                                                                          \(2017\) Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.          13        54               1.20 × 10^−10^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ANXA1,ANXA11,ANXA5,ANXA6,DCN,FBN1,LAMA1,LAMA2,LAMA4,LAMA5,NID1,NID2,THBS2
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------ --------- ---------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------
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###### 

Biological processes and PMIDs for the EV total unique proteins in the HIV group for the HIV vs. HIV+Aβ comparison.

  ------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------- -------------------------------------- --------------------------------------
  **Gene ontology (GO) Terms for Biological Processes**                                                                                                                                                                                                                                
  **Term Description**                                    **Obs**                                                                                                                                                           **Bgr**   **FDR**   **Matching Proteins in the Network**   
  Cell envelope organization                              2                                                                                                                                                                 3         0.0017    TGM1,TGM3                              
  **10 Most Significant PMID Publications per FDR**                                                                                                                                                                                                                                    
  **Term ID**                                             **Term Description**                                                                                                                                              **Obs**   **Bgr**   **FDR**                                **Matching Proteins in the Network**
  PMID:22329734                                           \(2012\) Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair.            3         14        0.0016                                 KLK7,TGM1,TGM3
  PMID:11093806                                           \(2000\) Transglutaminase-3, an esophageal cancer-related gene.                                                                                                   2         2         0.0136                                 TGM1,TGM3
  PMID:11562168                                           \(2001\) Crystallization and preliminary X-ray analysis of human transglutaminase 3 from zymogen to active form.                                                  2         2         0.0136                                 TGM1,TGM3
  PMID:11980702                                           \(2002\) Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.                            2         2         0.0136                                 TGM1,TGM3
  PMID:12850301                                           \(2003\) Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies.   2         3         0.0136                                 TGM1,TGM3
  PMID:14508061                                           \(2003\) A model for the reaction mechanism of the transglutaminase 3 enzyme.                                                                                     2         2         0.0136                                 TGM1,TGM3
  PMID:14645372                                           \(2004\) Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calciummagnesium.                                       2         2         0.0136                                 TGM1,TGM3
  PMID:14987256                                           \(2004\) Identification of calcium-inducible genes in primary keratinocytes using suppression-subtractive hybridization.                                          2         8         0.0136                                 KLK7,TGM1
  PMID:15084592                                           \(2004\) Crystal structure of transglutaminase 3 in complex with GMP: structural basis for nucleotide specificity.                                                2         2         0.0136                                 TGM1,TGM3
  PMID:15172109                                           \(2004\) Transglutaminase activity and transglutaminase mRNA transcripts in gerbil brain ischemia.                                                                2         3         0.0136                                 TGM1,TGM3
  ------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------- -------------------------------------- --------------------------------------
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###### 

Biological processes, KEGG pathways, and PMIDs for the EV total unique proteins in the HIV+Aβ group for the HIV vs. HIV+Aβ comparison.

  -------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- ---------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------
  **Gene Ontology (GO) Terms for Biological Processes**\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  **10 Most Significant Results per FDR (for All GO Terms, See [Supplementary Table S5A](#app1-ijms-21-02741){ref-type="app"})**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  **Term Description**                                                                                                             **Obs**                                                                                                                                                                 **Bgr**   **FDR**          **Matching Proteins in the Network**                                                                                                                                                                                                                                                                                                                                               

  Vesicle-mediated transport                                                                                                       41                                                                                                                                                                      1699      2.01 × 10^−13^   ACTR3,AP1G1,AP2B1,ARF6,ARPC4,CALR,CAND1,CAPZB,CAV1,CD9,CDC42,COPB2,ECM1,EEA1,EHD4,IGF2R,KPNB1,MME,NME1,PDIA6,PGM1,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,RAB1A,RAB2A,RALA,SLC44A2,SOD1,STOM,SYK,TGFB1,TIMP3,VAT1,XRCC6                                                                                                                                                 

  Localization                                                                                                                     66                                                                                                                                                                      5233      4.37 × 10^−11^   ACTR3,AP1G1,AP2B1,APOM,ARF6,ARPC4,CALR,CAND1,CAPZB,CAV1,CD9,CDC42,COPB2,CSE1L,DHX9,ECM1,EEA1,EHD4,FBN2,IGF2R,IGSF8,ILK,IPO5,IPO7,KPNB1,LMNA,MME,NME1,NRP1,PAFAH1B1,PDIA6,PGM1,PIP,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,RAB1A,RAB2A,RALA,RELN,RNF128,RPL14,RTN4,SLC3A2,SLC44A1,SLC44A2,SLIT2,SOD1,SPOCK1,STOM,SYK,TGFB1,THBS4,TIMP3,VAT1,VDAC1,VDAC2,WLS,XPO1,XRCC6   

  Secretion                                                                                                                        30                                                                                                                                                                      1070      8.12 × 10^−11^   CAND1,CAV1,CD9,ECM1,IGF2R,KPNB1,MME,NME1,PAFAH1B1,PGM1,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,RAB1A,RALA,SLC44A2,SOD1,STOM,SYK,TGFB1,TIMP3,VAT1,WLS,XRCC6                                                                                                                                                                                                              

  Transport                                                                                                                        57                                                                                                                                                                      4130      1.80 × 10^−10^   ACTR3,AP1G1,AP2B1,APOM,ARF6,ARPC4,CALR,CAND1,CAPZB,CAV1,CD9,CDC42,COPB2,CSE1L,DHX9,ECM1,EEA1,EHD4,IGF2R,IPO5,IPO7,KPNB1,LMNA,MME,NME1,NRP1,PAFAH1B1,PDIA6,PGM1,PIP,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,RAB1A,RAB2A,RALA,RPL14,SLC3A2,SLC44A1,SLC44A2,SOD1,STOM,SYK,TGFB1,TIMP3,VAT1,VDAC1,VDAC2,WLS,XPO1,XRCC6                                                      

  Secretion by cell                                                                                                                28                                                                                                                                                                      959       1.80 × 10^−10^   CAND1,CD9,ECM1,IGF2R,KPNB1,MME,PAFAH1B1,PGM1,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,RAB1A,RALA,SLC44A2,SOD1,STOM,SYK,TGFB1,TIMP3,VAT1,WLS,XRCC6                                                                                                                                                                                                                        

  Regulated exocytosis                                                                                                             24                                                                                                                                                                      691       2.67 × 10^−10^   CAND1,CD9,ECM1,IGF2R,KPNB1,MME,PGM1,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,SLC44A2,SOD1,STOM,SYK,TGFB1,TIMP3,VAT1,XRCC6                                                                                                                                                                                                                                                

  Exocytosis                                                                                                                       25                                                                                                                                                                      774       3.25 × 10^−10^   CAND1,CD9,ECM1,IGF2R,KPNB1,MME,PGM1,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,RALA,SLC44A2,SOD1,STOM,SYK,TGFB1,TIMP3,VAT1,XRCC6                                                                                                                                                                                                                                           

  Neutrophil activation involved in immune response                                                                                19                                                                                                                                                                      489       1.06 × 10^−8^    CAND1,IGF2R,KPNB1,MME,PGM1,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,SLC44A2,STOM,SYK,VAT1,XRCC6                                                                                                                                                                                                                                                                          

  Myeloid leukocyte activation                                                                                                     20                                                                                                                                                                      574       1.48 × 10^−8^    CAND1,IGF2R,KPNB1,MME,PGM1,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,SLC44A2,STOM,SYK,TGFB1,VAT1,XRCC6                                                                                                                                                                                                                                                                    

  Neutrophil degranulation                                                                                                         18                                                                                                                                                                      485       4.95 × 10^−8^    CAND1,IGF2R,KPNB1,MME,PGM1,PPIA,PSMD1,PSMD2,PSMD3,PYGB,PYGL,QSOX1,RAB10,RAB14,SLC44A2,STOM,VAT1,XRCC6                                                                                                                                                                                                                                                                              

  **KEGG Pathways**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  **Term description**                                                                                                             **Obs**                                                                                                                                                                 **Bgr**   **FDR**          **Matching Proteins in the Network**                                                                                                                                                                                                                                                                                                                                               

  Endocytosis                                                                                                                      10                                                                                                                                                                      242       0.00016          AP2B1,ARF6,ARPC4,CAPZB,CAV1,CDC42,EEA1,EHD4,IGF2R,RAB10                                                                                                                                                                                                                                                                                                                            

  Focal adhesion                                                                                                                   8                                                                                                                                                                       197       0.0012           CAV1,CDC42,ILK,LAMB2,PARVB,PPP1CB,RELN,THBS4                                                                                                                                                                                                                                                                                                                                       

  Bacterial invasion of epithelial cells                                                                                           5                                                                                                                                                                       72        0.003            ARPC4,CAV1,CDC42,ILK,SEPT2                                                                                                                                                                                                                                                                                                                                                         

  Pentose phosphate pathway                                                                                                        3                                                                                                                                                                       30        0.0278           G6PD,PGM1,RGN                                                                                                                                                                                                                                                                                                                                                                      

  Starch and sucrose metabolism                                                                                                    3                                                                                                                                                                       33        0.0278           PGM1,PYGB,PYGL                                                                                                                                                                                                                                                                                                                                                                     

  Proteoglycans in cancer                                                                                                          6                                                                                                                                                                       195       0.0278           CAV1,CDC42,LUM,PPP1CB,TGFB1,TIMP3                                                                                                                                                                                                                                                                                                                                                  

  Proteasome                                                                                                                       3                                                                                                                                                                       43        0.0347           PSMD1,PSMD2,PSMD3                                                                                                                                                                                                                                                                                                                                                                  

  Necroptosis                                                                                                                      5                                                                                                                                                                       155       0.0347           PPIA,PYGB,PYGL,VDAC1,VDAC2                                                                                                                                                                                                                                                                                                                                                         

  Fc gamma R-mediated phagocytosis                                                                                                 4                                                                                                                                                                       89        0.0347           ARF6,ARPC4,CDC42,SYK                                                                                                                                                                                                                                                                                                                                                               

  Amino sugar and nucleotide sugar metabolism                                                                                      3                                                                                                                                                                       48        0.0396           CHIA,PGM1,UGDH                                                                                                                                                                                                                                                                                                                                                                     

  HTLV-I infection                                                                                                                 6                                                                                                                                                                       250       0.0396           CALR,NRP1,TGFB1,VDAC1,VDAC2,XPO1                                                                                                                                                                                                                                                                                                                                                   

  **10 Most Significant PMID Publications per FDR**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  **Term ID**                                                                                                                      **Term Description**                                                                                                                                                    **Obs**   **Bgr**          **FDR**                                                                                                                                                                                                                                                                                                                                                                            **Matching Proteins in the Network**

  PMID:11149929                                                                                                                    \(2001\) The phagosome proteome: insight into phagosome functions.                                                                                                      9         47               3.12 × 10^−6^                                                                                                                                                                                                                                                                                                                                                                      ARF6,CALR,DFFA,P4HB,RAB10,RAB14,RAB2A,STOM,VDAC1

  PMID:17892558                                                                                                                    \(2007\) Quantifying raft proteins in neonatal mouse brain by 'tube-gel' protein digestion label-free shotgun proteomics.                                               10        83               6.99 × 10^−6^                                                                                                                                                                                                                                                                                                                                                                      ACTC1,BASP1,CAV1,CNTN1,RAB10,RAB14,RAB1A,RAB2A,SLC3A2,VDAC1

  PMID:22578496                                                                                                                    \(2012\) Harnessing the power of the endosome to regulate neural development.                                                                                           7         35               0.00014                                                                                                                                                                                                                                                                                                                                                                            ARF6,EEA1,EHD4,NRP1,RAB14,RTN4,WLS

  PMID:24009881                                                                                                                    \(2012\) Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.                                           11        161              0.00014                                                                                                                                                                                                                                                                                                                                                                            ACTR3,CAPZB,CD9,EHD4,ILK,RAB10,RALA,SLC3A2,SLC44A1,SYK,UGDH

  PMID:27770278                                                                                                                    \(2017\) Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.                                8         63               0.00016                                                                                                                                                                                                                                                                                                                                                                            ACTR3,CALR,ECM1,IGF2R,IPO5,PSMD2,RAB10TGFB1

  PMID:26205348                                                                                                                    \(2015\) Fluoxetine increases plasticity and modulates the proteomic profile in the adult mouse visual cortex.                                                          6         22               0.00023                                                                                                                                                                                                                                                                                                                                                                            AP1G1,CDC42,NME1,SOD1,VDAC1,VDAC2

  PMID:20140087                                                                                                                    \(2010\) Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.                                                 9         103              0.00024                                                                                                                                                                                                                                                                                                                                                                            DHX9,HNRNPK,KPNB1,LMNA,P4HB,PDIA6,RTN4,VDAC1,VDAC2

  PMID:27549615                                                                                                                    \(2016\) Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.                                       6         23               0.00024                                                                                                                                                                                                                                                                                                                                                                            LMNA,PAMR1,PPIA,PSMD2,SLIT2,THBS4

  PMID:23170974                                                                                                                    \(2012\) Integrated miRNA, mRNA and protein expression analysis reveals the role of post-transcriptional regulation in controlling CHO cell growth rate.                6         27               0.00044                                                                                                                                                                                                                                                                                                                                                                            HNRNPK,RAB10,RAB14,RAB1A,RAB2A,RPL14

  PMID:24505448                                                                                                                    \(2014\) Characterisation of four LIM protein-encoding genes involved in infection-related development and pathogenicity by the rice blast fungus Magnaporthe oryzae.   6         28               0.00047                                                                                                                                                                                                                                                                                                                                                                            CDC42,ILK,LMNA,PHGDH,RAB2A,XRCC6
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